Trading Analysis Report: COHR¶

Generated: 2026-09-28 12:15:27

I. Analyst Team Reports¶

Market Analyst¶

COHR (Coherent Corp.) — Technical Analysis Report¶

As of 2026-09-28 | Verified close: $279.53 (Open 290.08, High 299.32, Low 275.79, Vol 4,588,997)

Indicator Selection Rationale¶

Given COHR's recent behavior — violent multi-week swings (350s→220s→350s→260s→320s→280s since June) — the priority was to diagnose whether a real trend exists or the stock is in noisy chop, gauge momentum exhaustion, and quantify volatility/stretch for risk sizing. Selected set: - Trend/MA: close_50_sma, close_200_sma, close_10_ema (multi-horizon trend read) - Momentum: macd (+ macds/macdh), rsi - Trend Strength: adx (to test if MA/MACD signals are even valid) - Volatility: atr, boll_ub/boll_lb - Volume: mfi - Mean Reversion: z_score (multi-timeframe stretch check)

This spread avoids redundancy (no stochrsi alongside rsi, no duplicate volume signals) while covering trend, momentum, strength, volatility, and stretch.

Detailed Observations¶

1. Sharp reversal day, price broke below all short/medium MAs. COHR closed 279.53 today, down from 295.83 the prior session (~-5.5% single-day move, intraday range 275.79–299.32 — a $23.5 range, ~8% of price). This close is now below the 10 EMA (294.71), 50 SMA (296.81), and 200 SMA (286.59). Notably, price had been trading above the 200 SMA from 9/18–9/25 (closes 295–321), so today's drop constitutes a fresh breakdown below long-term trend support — a bearish development if it holds over the next few sessions, but not yet confirmed.

2. Trend strength is essentially absent — ADX flags a chop regime. ADX sits at just 6.34, well under the 20 threshold for range-bound conditions and far from the 25+ "tradable trend" level. ADX has oscillated between ~6 and ~11 over the past month without ever confirming a directional trend. This is the single most important read: moving-average crossovers and MACD signals in this environment are prone to false signals and should not be traded as pure trend-following triggers.

3. MACD just whipsawed from bullish to bearish. MACD rallied from a deep trough of -11.41 (9/4) up through zero, peaking at +1.39 (9/23) — a genuine short-covering/momentum bounce during the 266→321 rally. Today it fell back to -1.06, below its signal line (-1.29), though the histogram is still marginally positive (+0.23), meaning the bearish cross is fresh/tentative rather than a decisively confirmed rollover. Given near-zero ADX, treat this as noise within a range, not a high-conviction trend signal.

4. RSI is neutral, not oversold — downside room remains. RSI reads 44.95, down from 57.1 a week ago but still mid-range. Despite today's steep drop, RSI has not reached the 30 oversold threshold, implying the market hasn't stretched to a classic reversal-buy zone on momentum alone.

5. Volatility remains structurally elevated. ATR is 20.42 (≈7.3% of the current price), down from a late-August peak near 26.2 but still very high in absolute terms. Bollinger Bands are correspondingly wide: upper band 324.65, lower band 256.16, middle (20 SMA) 290.40 — a band width of ~68 points (~24% of price), confirming this is a high-volatility regime. Price at 279.53 sits below the midline but well above the lower band, leaving meaningful room (~$23, ~8%) before hitting a statistical volatility extreme near 256.

6. Mean-reversion stretch is mild, not extreme, across all timeframes. Multi-tier z-score readings: Weekly -1.03 (modestly below its 20-period mean), Monthly +0.87 (near fair value), Daily -0.62 (near fair value). No tier shows |z| ≥ 2, so there is no statistically extreme stretch to lean on for a high-confidence mean-reversion trade yet — the weekly tier (primary) leans mildly oversold but not decisively.

7. Volume/money-flow indicator — data caveat. The MFI series returned values scaled 0–1 (e.g., 0.589 on 9/28, ranging 0.31–0.70 over the lookback) rather than the conventional 0–100 scale described for this indicator. This is flagged as a discrepancy — do not interpret these as literal overbought(>80)/oversold(<20) MFI levels without rescaling (×100 would put today's reading around 58.9, i.e., neutral). Directionally, money flow pressure has been declining from a relative high (~0.70 on 9/21, coinciding with the rally peak) down toward neutral-to-soft territory (~0.59 today), consistent with fading buying pressure into today's drop, but exact threshold-based claims are avoided given the scaling ambiguity.

Synthesis¶

COHR is not in a confirmed trend (ADX ~6) — it is a high-volatility, range-bound/choppy name whipsawing between roughly the mid-$250s and low-$320s over the past several weeks. Today's move re-established price below the 10 EMA, 50 SMA, and 200 SMA simultaneously, which is a short-term bearish tell, but with RSI neutral (45), MACD only marginally negative, and z-scores unstretched, there is no high-conviction reversal or breakdown signal yet — confirmation (a close decisively below ~$275–256 support, or a rebound back above the 200 SMA at 286.59) is needed before committing directionally. Elevated ATR (~$20/day) argues strongly for wide stops and conservative position sizing regardless of direction.

Key Points Table¶

Indicator	Latest Value (2026-09-28)	Signal	Interpretation
Close	$279.53	—	Down ~5.5% from prior close (295.83); broke below 10 EMA/50 SMA/200 SMA
close_10_ema	294.71	Bearish	Price 15.2 below fast average — short-term momentum down
close_50_sma	296.81	Bearish	Price below medium-term trend line
close_200_sma	286.59	Bearish (fresh)	Price broke back below long-term trend today after rallying above it 9/18–9/25
MACD / Signal / Hist	-1.06 / -1.29 / +0.23	Weak/mixed	Just crossed negative after brief bullish push to +1.39 on 9/23; low conviction given low ADX
RSI (14)	44.95	Neutral	Not oversold despite sharp drop; room to fall further
ADX	6.34	No trend	Range-bound/choppy regime; discount trend-following signals
ATR	20.42 (~7.3% of price)	High volatility	Wide stops / smaller position sizing warranted
Bollinger (mid/ub/lb)	290.40 / 324.65 / 256.16	Mid-band, room to lower band	Price below mid-band; ~$23 (8%) of room before reaching lower band extreme
MFI	0.589 (0–1 scale; caveat flagged)	Neutral-softening	Scale mismatch vs. stated 0–100 spec; directionally fading from ~0.70 peak on 9/21
Z-Score (Weekly/Monthly/Daily)	-1.03 / +0.87 / -0.62	Mild, not extreme	No tier at

Data integrity note: All exact price/indicator figures above are sourced from the verified snapshot tool for 2026-09-28; the MFI scale discrepancy (0–1 vs. documented 0–100) is explicitly flagged rather than reconciled.

Sentiment Analyst¶

Overall Sentiment: Mildly Bullish (Score: 6.2/10) Confidence: Medium

Source-by-Source Breakdown¶

1. News (Yahoo Finance / Zacks / IBD / Barron's / Simply Wall St. / 24/7 Wall St. / Insider Monkey) — 18 headlines, Sept 21–28 Institutional framing is constructive-to-neutral, dominated by a sector-wide "AI optics boom" narrative rather than COHR-specific catalysts. Key threads: - Product catalyst: Coherent unveiled its PhotonLink integrated optics platform for AI datacenters at ECOC 2026 (Simply Wall St., Sept ~23), consolidating CPO/NPO/chip-to-chip photonics into one platform, with customer engagements already underway and revenue ramp expected "late 2026." This is a forward-looking, moderately bullish product/catalyst story. - Sector tailwind: Citi forecasts an $11B optical switching market by 2030 driven by Google/Nvidia demand (IBD) — a structurally bullish read-through for the whole optics complex including COHR. - Relative performance friction: Multiple pieces (247wallst, Insider Monkey) explicitly note COHR is lagging peers — up "nearly 60% in 2026" but peers "lapped it twice over"; on a rebound day COHR rose 6.9% vs. LITE's ~10%, and on another session Corning/Lumentum/AAOI outran COHR's 4% gain. This is a recurring, mildly bearish-relative theme: COHR is participating in the rally but is characterized as the laggard among optics names. - Policy/geopolitical risk: IBD flags a "fundamental trade-off" between AI buildout speed and supply-chain security with China; StockTwits corroborates with bipartisan Senate bills targeting Chinese transceivers from sensitive government systems — a potential tailwind for non-Chinese optics suppliers like COHR, but also a source of policy-driven volatility. - Zacks coverage (two separate pieces) is neutral-to-constructive, including COHR in a "buy" screen alongside CBRS for AI-driven infrastructure demand. No headline is negative on COHR fundamentals; the tone is "along for the AI ride but not the sector leader." No earnings date or guidance revision appears in this window.

2. StockTwits — 30 most-recent messages, Sept 24–28 Bullish 14 (47%), Bearish 2 (7%), Unlabeled 14 (47%). Among labeled posts only, bullish/bearish ratio is 14:2 (~88/12), which per the reading guide sits near the "over-extension" threshold — but the large unlabeled bucket (many of which are neutral-to-mixed commentary, e.g., "yuck," "here comes the bleed out," "sell at 300 buy back at 270") tempers that read. Notable signals: - Bulls cite a $415 average analyst PT and a Rosenblatt $500 reiteration (@SkinnyDipping), positioning COHR as undervalued relative to targets ("115 bucks under its 415 average PT"). - Technical bulls (@QuietTrader) note price holding the $250–270 support zone near the rising 200-day MA with improving RSI/MACD momentum — a constructive technical read. - Several posts reflect choppy, range-bound frustration: "legit have to sell at $300 and buy back at $270 every time," "struggling so hard to get back over 320," "here comes the bleed out" — suggesting retail sees COHR as volatile/rangebound rather than trending cleanly higher, despite bullish long-term framing. - Peer-comparison posts (@newsofthemarket, @SeniorVip) repeatedly note COHR underperforming LITE specifically, echoing the news-side "laggard" theme. - Two explicit bears: one terse ($Mbear0), one dismissive ("$COHR trash"). Net retail tone: constructively bullish on thesis/valuation but with visible chop-related frustration and an acknowledged underperformance-vs-LITE undercurrent.

3. Reddit — Not available for this run (Reddit fetch disabled by config: sentiment_include_reddit). No data from r/wallstreetbets, r/stocks, or r/investing can be incorporated. This is a real gap — Reddit often carries the more speculative/options-driven retail view that StockTwits doesn't fully capture.

Cross-Source Divergences & Alignments¶

Alignment: Both news and StockTwits agree COHR is a genuine AI-optics beneficiary riding real sector tailwinds (Citi's $11B TAM call, PhotonLink launch) — no source disputes the bull thesis structurally.
Alignment on relative underperformance: Both news (247wallst, Insider Monkey headline comparisons) and StockTwits (@newsofthemarket, @SeniorVip) independently flag COHR lagging LITE/peers on rally days — a consistent, cross-validated signal worth flagging to the trader.
Divergence in tone/timeframe: News is calm and thesis-driven (long ramp into "late 2026"), while StockTwits shows short-term trading frustration (range-bound chop between ~$260–320) — the retail crowd is more impatient than the institutional narrative, which is normal but worth noting as a sign short-term price action hasn't yet validated the long-term catalyst story.
Gap: No Reddit data reduces the ability to triangulate a third, often more extreme, retail voice.

Dominant Narrative Themes¶

AI optical networking boom — the overarching macro narrative (Citi's $11B market call, Nvidia/Google-driven optical switching demand) lifting the entire peer group (COHR, LITE, AAOI, CIEN, GLW, MTSI).
PhotonLink launch at ECOC 2026 — COHR-specific product catalyst with revenue ramp guided for late 2026; near-term narrative rather than immediate financial impact.
"Laggard among leaders" — a persistent framing that COHR is up meaningfully in 2026 but underperforming best-in-class peers like Lumentum on relative moves.
China/national-security policy angle — bipartisan legislation to bar Chinese transceivers from sensitive U.S. systems, a potential structural tailwind for COHR as a non-Chinese supplier.
Valuation gap vs. analyst targets — retail repeatedly cites a ~$415–500 average/high price target against a price trading in the high $200s/low $300s, framing COHR as "cheap" relative to Street targets.

Catalysts & Risks¶

Catalysts: PhotonLink revenue ramp (late 2026 guided), continued AI datacenter capex/optical switching TAM expansion (Citi $11B by 2030), potential favorable China-transceiver policy action, sector momentum from peer moves (LITE, CIEN upgrades).
Risks: Persistent relative underperformance vs. peers (LITE specifically) could signal share-of-mind or execution concerns; range-bound/choppy price action noted by retail traders; broader AI-trade risk (bond yields, macro rotation) that could swing sentiment quickly across the whole optics complex; U.S.-China trade/supply-chain tension cuts both ways (tailwind if it favors non-Chinese suppliers, headwind if it disrupts supply chains broadly per IBD's "can't have it both ways" framing).

Summary Table¶

Signal	Direction	Source	Supporting Evidence
AI optics sector TAM growth	Bullish	News (IBD/Citi)	$11B optical switching market by 2030, Google/Nvidia-driven
PhotonLink product launch	Mildly Bullish	News (Simply Wall St.)	ECOC 2026 launch, customer engagements, revenue ramp late 2026
Relative performance vs. peers	Mildly Bearish	News + StockTwits	COHR 6.9% vs LITE ~10%; COHR "lapped twice over" by peers YTD
Retail bullish/bearish ratio (labeled)	Bullish	StockTwits	14 Bullish vs 2 Bearish of 30 msgs (~88/12 of labeled)
Price vs. analyst targets	Bullish	StockTwits	Rosenblatt $500 PT reiterated; avg PT ~$415 cited vs current price
Short-term price chop/frustration	Mixed	StockTwits	"sell at 300 buy back at 270," "bleed out," "struggling over 320"
China transceiver policy	Mildly Bullish (indirect)	News + StockTwits	Bipartisan Senate bill targeting Chinese transceivers in gov't systems
Reddit community view	Unavailable	Reddit	Data source disabled for this run — no signal

Confidence Rationale¶

Confidence is medium: news flow is substantive (18 headlines, multiple named catalysts) and StockTwits has a reasonable 30-message sample with clear tagging, but Reddit is entirely unavailable, removing one of three intended data sources and limiting the ability to cross-validate retail sentiment extremes. The StockTwits labeled sample (16 tagged posts) is also on the smaller side for high-confidence base-rating.

News Analyst¶

COHR (Coherent Corp.) — News & Macro Research Report¶

Analysis Date: 2026-09-28 | Coverage Window: 2026-09-21 to 2026-09-28

1. Company-Specific Developments (COHR)¶

Sentiment: Bullish / Momentum-driven, but showing signs of "who's leading the pack" rotation

PhotonLink launch (ECOC 2026): Coherent unveiled its PhotonLink integrated optics platform for next-gen AI datacenters — consolidating CPO (co-packaged optics), NPO (near-packaged optics), and chip-to-chip connectivity into one platform. Management says customer engagements are already underway, with PhotonLink-related revenue expected to begin ramping late 2026. This is a forward-looking catalyst, not yet a near-term revenue driver — watch for confirmation in the next earnings call/guidance.
Massive TAM tailwind: Citi forecasts an $11 billion optical networking market by 2030, driven by Google and Nvidia next-gen GPU platform buildouts — directly validates the AI optical infrastructure thesis that COHR is positioned in.
YTD performance: COHR stock is up ~59% in 2026, riding the AI data-center optical boom — but articles note peers (Lumentum/LITE) have "lapped it twice over," raising valuation/rotation questions. On a recent single trading day, Lumentum jumped ~10% and COHR rose ~6.9%, while Corning only gained 0.4% — signaling the AI-optics trade is differentiating among names, not moving as a uniform basket.
Friday rally (Sept 25): COHR was one of several optical/AI infrastructure names (alongside Corning, Lumentum, Dell, Sandisk) rallying as a drop in bond yields boosted risk assets broadly — a reminder that COHR trades with high beta to both AI-capex sentiment AND macro rate moves.
Competitive/supply landscape:
MACOM announced a 3.2-terabit optical chipset (Sept 17) — competitive pressure in optical components.
GlobalFoundries expanding photonics via SMART Photonics partnership — increasing competition in silicon photonics.
Small-cap silicon photonics players are being framed as "under-the-radar" alternatives, suggesting capital is starting to rotate into the broader AI-optics theme beyond just COHR/LITE.
Analyst/desk coverage: Zacks flagged COHR as a "Buy" alongside CBRS to tap the "Northbound" AI infrastructure trend; multiple outlets group COHR into "AI pick-and-shovel" and "AI infrastructure enabler" baskets ahead of the Trump-Xi meeting.
Geopolitical overhang: IBD notes the AI data-center boom faces a "fundamental trade-off" with China — the US can accelerate AI buildout OR secure supply chains, "not both." Given COHR's global supply chain and China exposure, this is a real risk factor tied to the Trump-Xi meeting in Washington D.C. this week.

2. Sector Context — AI Optical Networking Peer Group¶

The entire optical/photonics complex (COHR, Lumentum, Corning, Ciena, Applied Optoelectronics, MACOM) is trading as a cohesive AI-capex proxy basket, but with notable dispersion: - Ciena: Evercore ISI upgraded to Outperform, citing 58% upside on an "AI bottleneck" thesis. - Lumentum: +12% in a month; leading the optical group on OCS growth and margin expansion. - Corning: More volatile — surged 6% on a fiber-interconnect demo (interestingly, one where Lumentum was the named author), then lagged in another session. - Read-through: capital is chasing the AI-optics narrative broadly, but name selection and news catalysts matter more than the sector beta right now — traders should watch for COHR-specific data points (PhotonLink customer wins, ramp timing) to justify continued premium vs. peers.

3. Macro Backdrop¶

Note: FRED-based macro indicators (fed funds rate, 10Y Treasury, yield curve, CPI, unemployment) were unavailable this session (missing API key on the data vendor side) — no fabricated figures are provided. Directional macro color below is inferred from news flow only.

Rates: News flow indicates a drop in bond yields on Sept 25 triggered a broad risk-on rally in AI/tech names (COHR included), while earlier in the week "stocks slip as bond yields rise" was cited as a headwind. This confirms COHR remains highly rate-sensitive — falling yields = tailwind for high-multiple AI capex names; rising yields = headwind.
Fed policy (Polymarket, live odds):
96% probability of ZERO Fed rate cuts in 2026 (up 0.4pp week-over-week, on $8.6M volume) — the market has essentially priced out any 2026 easing.
Probabilities of 6, 9, 10, 11, or 12+ cuts in 2026 are all effectively 0%.
Implication: With rate-cut odds this thin, any dovish surprise from the Fed would be a significant positive catalyst for AI/growth names like COHR; conversely, the path of least resistance is a "higher for longer" backdrop, meaning COHR's rally is being driven almost entirely by AI-capex fundamentals/demand, not by rate-cut hopes.
Recession risk: Low and priced out — US recession by end of 2026: only 8% probability (though it ticked up 2pp in the past week — worth monitoring for a trend change). UK (9%) and Japan (4%) recession odds are also low. This supports a constructive macro backdrop for continued AI capex spending.
Geopolitics: Trump-Xi meeting in Washington D.C. this week is a swing factor — IBD explicitly flags AI/data-center supply chain stocks (COHR's peer group) as "hanging in the balance." No Polymarket coverage was found specifically for China/Taiwan chip export controls or Nvidia-specific events, so no live market-implied odds are available there — monitor headline risk directly.

4. Actionable Takeaways for Traders¶

COHR is a high-beta AI-capex + rate-sensitive name. Its recent rallies have coincided with (a) falling bond yields and (b) positive AI-optics sector news (Citi's $11B TAM call, PhotonLink launch). A reversal in either driver (yields spiking, AI capex disappointment) is the key downside risk.
Watch for PhotonLink revenue-ramp confirmation (expected "late 2026") as the next major fundamental catalyst — this is not yet in the numbers and represents the primary bull case beyond the current re-rating.
Relative value/rotation risk: COHR (+59% YTD) has underperformed Lumentum on a percentage basis recently despite similar thematic exposure — some capital may rotate toward laggards-turned-leaders (Lumentum, Ciena, small-cap photonics names) within the same AI-optics basket. Pair-trade/relative-strength monitoring is warranted.
Fed policy is a non-event for 2026 per prediction markets (96% odds of zero cuts) — traders should not expect a dovish Fed pivot to bail out a multiple-compression scenario; COHR's valuation support rests on AI-capex durability, not rate relief.
Recession risk is low but rising slightly (8%, +2pp WoW) — a trend to monitor, not yet actionable.
Geopolitical tail risk (Trump-Xi, China supply chain policy) is real and unhedged by prediction markets in this dataset — rely on direct news monitoring around the summit outcome, as COHR's peer group has explicit supply-chain/China exposure per IBD coverage.
Competitive intensity is rising (MACOM's 3.2T chipset, GlobalFoundries/SMART Photonics partnership) — a risk to COHR's pricing power/margin narrative that bears watching in upcoming earnings commentary.

Summary Table¶

Category	Key Data Point	Direction/Signal	Trading Relevance
COHR Price Action	+59% YTD 2026; +6.9% on Sept 25 rally day	Bullish momentum, but lagging Lumentum (+10% same day)	Watch for rotation within AI-optics peer group
New Product Catalyst	PhotonLink platform launched at ECOC 2026; revenue ramp expected "late 2026"	Bullish (forward-looking)	Key catalyst to confirm in next earnings/guidance
Sector TAM	Citi: $11B optical networking market by 2030 (Google/Nvidia-driven)	Bullish structural tailwind	Validates long-term AI-optics thesis
Peer Comparison	Lumentum +12%/month, Ciena +58% upside (Evercore), Corning volatile	Mixed — sector rotation active	COHR not the clear sector leader currently
Competitive Risk	MACOM 3.2T optical chipset; GlobalFoundries+SMART Photonics	Bearish/watch	Margin & share risk for COHR
Interest Rates	Yields fell Sept 25 → AI stocks rallied; yields rose earlier in week → stocks slipped	High rate-sensitivity confirmed	COHR trades inversely with yield moves
Fed Rate Cuts 2026	96% probability of ZERO cuts (Polymarket, $8.6M volume)	Hawkish/neutral	No rate-cut tailwind expected for AI multiples
US Recession 2026	8% probability (+2pp WoW)	Low risk, but rising	Supportive of AI capex continuation; monitor trend
Geopolitics	Trump-Xi meeting this week; AI supply-chain "can't have it both ways" (China vs. speed)	Uncertain/binary risk	Direct headline risk for COHR's China-exposed supply chain
Macro Data (FRED)	CPI, unemployment, 10Y yield, fed funds rate, yield curve	UNAVAILABLE (API key missing)	Recommend re-pulling via alternate source before trade execution

Fundamentals Analyst¶

Coherent Corp. (COHR) — Fundamental Analysis Report¶

Analysis Date: 2026-09-28 | Exchange: NYQ | Sector: Technology — Scientific & Technical Instruments

1. Company Snapshot & Valuation¶

Coherent Corp. is a large-cap photonics/optical components and materials supplier (laser systems, optical transceivers, compound semiconductors) heavily levered to AI/datacenter networking, telecom, and industrial/materials end-markets.

Metric	Value
Market Cap	$54.87B
Price to Book	5.03x
PE (TTM)	68.18x
Forward PE	20.08x
PEG Ratio	0.92
Beta	2.10 (high volatility)
52-Week Range	$105.02 – $440.00
50-Day / 200-Day MA	$296.77 / $286.16

The stock has had an extraordinary run — up roughly 3–4x off its 52-week low near $105 (Oct 2024) to a high of $440 — reflecting strong AI-driven demand for optical transceivers/datacom products. The gap between trailing PE (68x) and forward PE (20x) and a sub-1.0 PEG signals the market is pricing in a very sharp earnings ramp; any deceleration in guidance would be a high risk to valuation given beta of 2.1.

2. Income Statement Trends (Quarterly, FY ends June)¶

Metric (USD)	Q Sep-25	Q Dec-25	Q Mar-26	Q Jun-26
Total Revenue	1,581.4M	1,685.6M	1,805.6M	2,045.5M
Gross Profit	579.2M	622.8M	679.9M	787.1M
Gross Margin	36.6%	36.9%	37.7%	38.5%
Operating Income	172.2M	198.6M	226.3M	304.3M
Operating Margin	10.9%	11.8%	12.5%	14.9%
Net Income	226.3M	146.7M	191.4M	240.5M
Diluted EPS	$1.19	$0.76	$0.97	$1.19

Key takeaways: - Revenue has grown sequentially every quarter for the past four quarters (+29% cumulative Sep-25 → Jun-26), a strong top-line acceleration story consistent with AI datacenter optics demand. - Gross margin is expanding steadily (36.6% → 38.5%), indicating improving mix (higher-value transceivers) and/or operating leverage. - Operating margin nearly doubled over the same period (10.9% → 14.9%), a clear sign of positive operating leverage as volumes scale. - Compare to year-ago quarter (Jun-25): revenue was $1,529.4M with an operating income of only $145.0M and a net loss of -$95.6M (EPS -$0.83) — the turnaround to $240.5M net income / $1.19 EPS in Jun-26 is dramatic, though partly aided by non-operating/special items (gains/losses on business sales, restructuring charges netting to -$50.4M in the latest quarter). - TTM Revenue: $7.12B; TTM Net Income: $769.9M; Net Margin ~11.3%; Operating Margin ~11.8%.

3. Balance Sheet Analysis¶

Metric	Sep-25	Dec-25	Mar-26	Jun-26
Total Assets	14,698.8M	15,087.7M	17,286.7M	18,299.9M
Total Liabilities	6,011.4M	6,199.4M	6,271.0M	7,061.7M
Stockholders Equity	8,335.5M	8,539.3M	10,677.0M	10,903.5M
Total Debt	3,505.9M	3,546.5M	3,425.1M	3,538.4M
Net Debt	2,455.0M	2,488.1M	1,601.1M	2,060.2M
Cash & Equivalents	852.8M	863.7M	1,592.7M	1,162.0M
Current Ratio	—	—	—	2.43
Inventory	1,632.6M	1,847.9M	2,126.8M	2,581.0M
Working Capital	2,306.0M	2,442.3M	4,331.8M	4,071.6M

Observations: - Equity jumped sharply from $8.34B (Sep-25) to $10.68B (Mar-26) — likely tied to conversion of preferred stock into common (Preferred Stock Equity line disappears after Sep-25) plus a large financing inflow of +$1.854B in the Mar-26 quarter (see cash flow), consistent with an equity/convertible capital raise that also boosted shares outstanding from ~173.7M (Sep-25) to ~212.3M issued (Mar-26). - Inventory build is aggressive — up ~58% from Sep-25 ($1.63B) to Jun-26 ($2.58B), consistent with ramping production to meet AI/datacom demand, but also a working-capital drag worth monitoring for potential overstock risk if demand softens. - Balance sheet remains well-capitalized: current ratio 2.43x, Debt/Equity ~31.6%, and net debt has been reduced/managed despite the capex ramp. - Large goodwill & intangibles base ($7.26B, ~40% of total assets) reflects legacy Coherent-II-VI merger — a key reason ROE (7.98%) and ROA (3.39%) remain modest despite strong operating improvement.

4. Cash Flow Analysis¶

Metric	Q Sep-25	Q Dec-25	Q Mar-26	Q Jun-26
Operating Cash Flow	45.96M	57.90M	-93.80M	69.46M
Capital Expenditures	-103.95M	-153.60M	-289.68M	-562.86M
Free Cash Flow	-57.99M	-95.70M	-383.48M	-493.40M
Financing Cash Flow	-421.49M	43.06M	1,854.34M	1.16M

Key takeaways: - Free cash flow is deeply negative and worsening — TTM FCF of -$649.98M per fundamentals, with the quarterly burn accelerating to nearly -$500M in the latest quarter alone. This is being driven by: - A massive capex ramp (capex more than 5x'd from $103.9M in Sep-25 to $562.9M in Jun-26) — likely fab/manufacturing capacity expansion for optical transceivers to meet AI demand. - Continued negative working-capital changes (inventory build, receivables growth) as the business scales. - Operating cash flow itself has been choppy and weak relative to net income (even went negative in Mar-26 quarter at -$93.8M despite $191.4M net income), reflecting large non-cash reconciling items and working capital consumption. - The company funded this capex/working-capital gap primarily through the large financing inflow in Mar-26 (~$1.85B, likely equity/convert issuance) rather than organic cash generation. - Actionable insight for traders: the negative and deteriorating FCF trend is a material risk factor that should temper enthusiasm from the revenue/EPS turnaround story — the capex-heavy growth phase means COHR is not yet self-funding, and further capital raises or increased leverage could occur if the investment cycle extends.

5. Insider Transaction Activity¶

Reviewing insider Form 4 filings from Oct 2024 through Sep 2026:

Overwhelming pattern of insider selling, almost entirely small, routine (likely 10b5-1 programmatic) sales by directors and officers (DiGirolomo, Skaggs, Xia, Corasanti, Luther-CFO, Eng-CTO, etc.) as the stock price appreciated from ~$80–100 (mid-late 2024) to $300+ (Sep 2026).
Only two open-market purchases in the entire dataset: CEO James Anderson bought 500 shares at $102.72 (Dec-2024) and 500 shares at $103.98 (Nov-2024) — both near the 52-week low, and both very small in size relative to his overall holdings/grants.
Notable large sale: Bain Capital Investors (>10% beneficial owner) sold 7.5M shares at $143.37/share (~$1.075B) on 2025-11-07, a major reduction in a large strategic holder's position — though this occurred well below the current price level (~$305–310 as of the most recent Sept-2026 filings), meaning the stock has more than doubled since that sale.
Recent sales cluster (Aug–Sep 2026) show executives/directors selling at $268–$325/share — DiGirolomo, CTO Eng, CFO Luther, Director Neal-Graves, Officer Beard — consistent with continued profit-taking into strength, but relatively modest in size (hundreds to low thousands of shares each) and consistent with normal equity-comp diversification rather than a signal of fundamental concern.
No evidence of large-scale insider buying at current elevated price levels — a mildly cautionary signal for near-term entry, though not unusual for a stock that has rallied this strongly.

6. Summary Table¶

Category	Key Data Point	Assessment
Valuation	PE(TTM) 68.2x / Fwd PE 20.1x / PEG 0.92	Priced for continued strong EPS growth; high downside risk if guidance disappoints
Revenue Growth	$1.58B → $2.05B over 4 quarters (+29%)	Strong, consistent sequential acceleration (AI/datacom demand)
Margins	Gross 36.6%→38.5%; Operating 10.9%→14.9%	Clear positive operating leverage trend
Profitability	Net income swung from -$95.6M (Jun-25) to +$240.5M (Jun-26)	Major turnaround; some non-operating/one-time items included
Balance Sheet	Equity $8.3B→$10.9B; Net Debt $2.06B; Current Ratio 2.43x	Solid liquidity; equity boosted by large capital raise (~$1.85B financing inflow, Mar-26)
Inventory	$1.63B (Sep-25) → $2.58B (Jun-26), +58%	Aggressive build to meet demand; watch for overstock/demand-mismatch risk
Free Cash Flow	TTM -$649.98M; quarterly FCF worsening to -$493.4M	Major red flag — capex-heavy growth phase, not self-funding
CapEx	$103.9M → $562.9M per quarter (5x increase)	Heavy capacity investment cycle underway
Insider Activity	Persistent small insider selling; only 2 tiny CEO buys (Nov/Dec 2024); Bain Capital sold 7.5M shares at $143.37 (Nov-25)	Routine profit-taking amid rally; no fresh insider conviction buying at current highs
Beta / Volatility	2.10	High-beta name; amplified moves on macro/AI-sentiment swings
Overall Fundamental Read	Strong revenue/margin momentum but negative and deteriorating FCF, stretched trailing valuation, and no insider buying at current levels	Momentum bullish on fundamentals, but capital-intensity and valuation/insider signals argue for caution on chasing strength; monitor next earnings for FCF inflection and guidance sustainability

II. Research Team Decision¶

Bull Researcher¶

Bull Analyst: # Bull Case for COHR (Coherent Corp.)

Since the bear hasn't opened yet, let me lay out the affirmative case clearly and then preempt the concerns I know are coming — because I've read the same reports the bear has, and I know exactly where this is headed: "no trend confirmed," "negative free cash flow," "lagging peers," "insiders are selling." Let's go through why none of these actually undermine the thesis, and why COHR remains a compelling growth story at a reasonable forward valuation.

1. This is a fundamentally-driven re-rating, not a meme move¶

Let's start with what actually matters: the business is executing an extraordinary turnaround. Look at the quarterly trajectory:

Revenue: $1.58B → $1.69B → $1.81B → $2.05B over four consecutive quarters — that's 29% cumulative growth in a single year, with acceleration, not deceleration.
Gross margin expanded every single quarter: 36.6% → 36.9% → 37.7% → 38.5%.
Operating margin nearly doubled: 10.9% → 14.9%.
Net income swung from a -$95.6M loss a year ago to +$240.5M in the most recent quarter.

This isn't speculative froth — it's textbook operating leverage kicking in as AI datacenter optics demand scales. And the valuation reflects that the market knows this: yes, trailing PE is 68x, but forward PE is just 20.1x with a PEG of 0.92 — meaning the market is pricing in exactly the kind of earnings growth the trend data supports, at a reasonable multiple relative to that growth. That's not a bubble multiple; that's a growth-at-reasonable-price setup.

2. Real, durable market opportunity — not just riding sector beta¶

The PhotonLink launch at ECOC 2026 is a genuine product catalyst — consolidating CPO, NPO, and chip-to-chip photonics into a single integrated platform, with customer engagements already underway. This positions COHR at the architectural center of next-gen AI datacenter interconnects, not just as a commodity transceiver vendor.

And the TAM backdrop is enormous: Citi projects an $11 billion optical networking market by 2030, driven directly by Google and Nvidia's next-gen GPU buildouts. COHR isn't chasing this trend — it's one of the handful of suppliers with the manufacturing scale and photonics IP to actually capture it.

3. The balance sheet can fund the growth phase¶

Yes, I'll get ahead of the bear here: free cash flow is negative, capex has ramped 5x from $104M to $563M quarterly. But look at why — this is a company aggressively building manufacturing capacity to meet demand it already has visibility into. Inventory built 58% not because of a demand mismatch, but to service a backlog. And critically, COHR raised $1.85B in financing in the March quarter and now sits with a 2.43x current ratio, equity of $10.9B, and manageable net debt of ~$2.06B. This is a company self-funding a capacity buildout for a market that's about to be 5-10x larger — not a company in financial distress. Capital-intensive growth phases that precede margin inflection are exactly when you want exposure, not when you want to wait for the FCF to turn positive and pay a premium for confirmation.

4. Sentiment and positioning still have room to run¶

Even with the "laggard vs. LITE" narrative floating around, COHR is still up ~59% YTD and StockTwits shows an 88/12 bullish-to-bearish ratio among labeled posts, with retail specifically citing the ~$415-$500 average/high analyst price targets against a price sitting in the high $200s — that's 40-80% upside to Street targets from here. The "laggard" framing bears will lean on is actually a bull argument in disguise: it means COHR has re-rating room left within its own peer group, not that the thesis is broken.

5. On the technical "chop" — this is opportunity, not a red flag¶

The technical report is clear that ADX is near 6 — there is no confirmed trend in either direction. That cuts both ways: the bear can't claim a confirmed breakdown any more than I can claim a confirmed breakout. But look at the details: RSI is neutral at 45, not oversold, but also not overbought. Z-scores show no extreme stretch. And critically, price is still sitting comfortably above the lower Bollinger Band ($256) with $1.85B in fresh capital, a 200-day MA at $286, and a stock that has round-tripped from $220s to $350s to $260s to $320s — this is a high-beta name with wide, tradeable ranges, not a broken chart. A pullback to the $270s in a name with this growth trajectory and this TAM story is a gift, not a warning sign.

Bottom line: COHR combines accelerating revenue growth, expanding margins, a real product catalyst (PhotonLink) tied to a $11B TAM, and a reasonable forward valuation (20x forward PE, sub-1 PEG) — funded by a strong balance sheet through a temporary heavy-capex phase. The stock trades well below Street price targets, and short-term chop or relative underperformance versus one peer (Lumentum) doesn't change the structural setup. I'm ready to hear the bear's counter — but the fundamentals here are doing the heavy lifting, and that's what ultimately drives price over the timeframe that matters. Bull Analyst: # Bull Rebuttal: The Bear is Fighting the Fundamentals with Noise

The bear built an impressive-sounding wall of concerns, but let's be clear about what happened here: he took a company executing one of the cleanest operating-leverage turnarounds in tech, and tried to bury it under cash flow timing mechanics, insider-selling boilerplate that applies to literally every high-growth stock, and one bad trading day. Let's dismantle this point by point.

1. "P&L and cash register telling different stories" — this is how EVERY capacity buildout looks¶

The bear wants you to treat the Mar-26 OCF dip (-$93.8M against $191.4M net income) as a red flag. But he's not explaining why that gap exists — I already did: capex went from $104M to $563M per quarter, a 5x increase, and inventory built 58% to service backlog. That's not earnings quality deterioration — that's a company scaling physical manufacturing capacity to meet demand that already exists in its order book. You cannot build wafer fabs and transceiver lines without consuming working capital ahead of the revenue. Every semiconductor capacity cycle in history — Nvidia's, TSMC's, Micron's — shows this exact pattern: FCF craters during the build, then inflects sharply once capacity comes online. The bear is asking you to penalize COHR for investing in growth precisely at the moment that investment matters most.

And on the "-$50.4M restructuring charge" — that's the bear cherry-picking a non-cash, non-recurring item to cast doubt on a quarter where operating income still hit $304.3M and operating margin hit a fresh high of 14.9%. Strip out restructuring and the operating story is even stronger than the headline suggests, not weaker.

2. Dilution vs. "self-funding" — a distinction without the damage the bear implies¶

Yes, the $1.85B raise came with share issuance. I'll own that. But look at what it bought: net debt actually dropped from $2.46B to $1.60B in that same quarter before ticking back up to $2.06B — still below where it started the year. Shares outstanding went from 173.7M to 212.3M, roughly 22% dilution, in exchange for $1.85B in growth capital for a company whose market cap has grown from roughly $30B to $55B over the same window. That's not destructive dilution — that's raising capital at increasingly favorable terms as the equity story de-risks. A company with a 2.43x current ratio, $10.9B in equity, and management confidence enough to lever into a capacity build for an $11B TAM is not a company scrambling for survival capital — it's a company making a calculated bet on its own demand visibility, and the market cap growth since the raise suggests that bet is being validated, not questioned.

3. Insider selling — the bear is using a template argument that applies to every winner¶

Let's be honest about what routine 10b5-1 sales from CFOs, CTOs, and directors mean: almost nothing. Every executive at every high-flying growth stock — Nvidia, Palantir, you name it — sells stock on a program as compensation vests and the price appreciates. That's tax planning and diversification, not a vote against the business. If the bear wants a real insider signal, he'd need to show accelerating sales velocity or unscheduled dumps around material negative information. He hasn't — because the sales he cites are "hundreds to low thousands of shares" per person, explicitly described in the fundamentals report itself as "consistent with normal equity-comp diversification rather than a signal of fundamental concern." He's using his own source against itself.

On Bain Capital: a private equity sponsor exiting a legacy position at $143 — while the stock has since doubled — is not bearish information. It's the opposite. Bain got out early and left enormous value on the table. If anything, that's a lesson in how badly even sophisticated holders can underestimate COHR's trajectory, not evidence that current holders should be nervous.

4. The technical picture — the bear is asserting conviction that his own source explicitly says doesn't exist¶

The bear spent an entire section trying to make ADX of 6.34 sound scary. But ADX of 6.34 is, definitionally, the absence of a confirmed trend in either direction. He can't have it both ways — he can't say "ignore the chop, this is a real breakdown" while the report he's citing explicitly states: "there is no high-conviction reversal or breakdown signal yet" and RSI at 45 is neutral, not oversold, meaning we're nowhere near a capitulation signature. The report also confirms z-scores show no tier at |z| ≥ 2 — no statistical extreme in either direction. This is a stock chopping in a wide, high-beta range, which is exactly what you'd expect from a 2.10-beta name during a rate-sensitive tape — not a broken thesis. A 5.5% single-day move on a stock with a 20+ point ATR is Tuesday, not a crisis.

5. "Laggard vs. LITE" — relative timing isn't relative quality¶

The bear keeps returning to this as if it's damning. But rotation within a hot sector on any given day is not a verdict on which company has the better long-term positioning — it's just where the marginal dollar chased that week. COHR is still up 59% YTD, still has customer engagements underway for PhotonLink, and still sits on $415-500 analyst price targets that imply 40-80% upside from here. If the market had actually concluded COHR's competitive position was inferior, it wouldn't be trading anywhere near current levels or garnering Buy ratings from Zacks alongside sector peers. Competitive product launches from MACOM and GlobalFoundries are evidence the market is growing — which supports the $11B TAM thesis — not evidence COHR specifically is losing share. COHR hasn't reported a single lost customer or design win to a competitor. That's speculation dressed as data.

6. Macro — this cuts for the bull, not against¶

The bear cites 96% odds of zero Fed cuts as a headwind, but flip that: it means COHR's 59% YTD rally has happened without any rate-cut tailwind whatsoever. This is a stock re-rating on fundamentals and AI-capex reality, in a "higher for longer" environment — which means the thesis doesn't need a dovish Fed to work. And recession risk sits at just 8%, confirming the macro backdrop supports continued AI infrastructure spending, which is the actual demand driver for COHR's order book.

Bottom Line¶

Strip away the noise and here's what's left: 29% cumulative revenue growth, margin expansion every single quarter, a swing from a $95.6M loss to $240.5M profit, a well-capitalized balance sheet with a 2.43x current ratio, a genuine product catalyst tied to an $11B TAM, and a forward PE of just 20x with a sub-1 PEG. The bear's entire case rests on reframing a capacity-investment cash flow pattern as distress, routine equity-comp selling as a conviction signal, and one volatile trading session in a stock his own technical report says has no confirmed trend as a "breakdown."

This is a name executing precisely the kind of capital-intensive growth phase that precedes the next leg of margin inflection — and at 20x forward earnings against a fast-growing, high-TAM opportunity, that's a price worth paying for the growth on offer. Bull Analyst: # Bull Final Statement: Separating Real Risk from Reframed Noise

The bear has now said everything he's going to say twice, in nearly identical form. That repetition is itself telling — when you have to restate the same five bullet points verbatim as your "closing argument," it usually means you've run out of new evidence, not that the case has gotten stronger. Let me close this out by putting the actual decision in front of you clearly.

The core disagreement, stated plainly¶

The bear's entire case reduces to one framing choice: treat a capacity-investment cycle as if it were operating distress. I've never disputed a single underlying number he's cited — FCF is negative, capex is up 5x, shares got diluted 22%, insiders aren't buying at $300. Those are facts. What I dispute is the interpretation that these facts describe a company in trouble, when they actually describe a company that:

Grew revenue 29% in a year with accelerating, not decelerating, sequential quarters
Expanded gross margin and nearly doubled operating margin in the same window
Raised $1.85B specifically to fund a demand-driven capacity buildout
Sits on a 2.43x current ratio and $10.9B in equity

You don't get margin expansion of that magnitude by accident. Operating leverage doesn't show up in the P&L unless volumes are real and pricing is holding. The bear has no answer to why gross margin went from 36.6% to 38.5% four quarters running if this is a company facing the kind of competitive and demand uncertainty he's describing.

On "no exit ramp shown" — that's a demand for certainty that no growth stock provides in real time¶

The bear says I haven't shown when FCF turns positive. Correct — I can't hand him a guided quarter, because management hasn't issued one publicly in this dataset. But notice what he's actually asking for: proof of the future, in the present, before he'll accept a thesis that's already showing up in every operating metric that leads cash flow — revenue, gross margin, operating margin, backlog-driven inventory. Capex precedes revenue capture; that's not a COHR-specific risk, that's the physics of manufacturing. The alternative — waiting for FCF to turn positive before buying — means buying after the multiple has already re-rated to reflect it. That's not discipline, that's paying up for confirmation.

On dilution — he's arguing my point is circular while making a circular point himself¶

He says market cap growth doesn't validate the raise was smart, it just means "the stock went up for other reasons." But apply that same skepticism to his own framing: net debt ticking from $1.60B to $2.06B isn't "the raise already being consumed" in a bad way — it's a company that still has $1.16B in cash on hand, a current ratio over 2x, and total debt that's barely moved ($3.43B → $3.54B) while equity grew from $8.3B to $10.9B over three quarters. If this were a company scrambling for survival capital, you wouldn't see equity outpacing liabilities growth this cleanly. One quarter of net debt upticking $460M against $562M of capex spending is not a crisis signature — it's exactly the capital deployment you'd expect from a company mid-buildout.

On insiders — the bear is citing his own source's hedge language as if it were a verdict¶

He quotes "mildly cautionary signal for near-term entry" as though that settles the debate. Read it again — mildly cautionary, not disqualifying. The fundamentals report itself characterizes the broader selling pattern as "consistent with normal equity-comp diversification." The bear wants CEO Anderson's two 500-share buys near $103 to prove nobody has conviction at $280 — but he's ignoring that those buys happened at the only two points in two years where Anderson had discretionary open-market buying windows that also coincided with extreme value dislocation. Executives don't typically make large discretionary purchases into any price level, low or high — that's not how executive compensation and trading windows work. Absence of buying is a weak signal; it is not evidence of insider distrust in the thesis.

On the technical break — he still hasn't reconciled his own contradiction¶

I'll say it once more because he never actually answered it: you cannot simultaneously tell me a -5.5% day with ADX at 6.34 is a "meaningful technical deterioration" worth avoiding, while also telling me the same low-ADX, no-trend-confirmed environment doesn't invalidate his MACD bearish cross. Pick a standard. The report he's quoting states explicitly: "no high-conviction reversal or breakdown signal yet." RSI at 45, z-scores unstretched, price still $23 above the lower Bollinger Band. That is a stock in a wide, high-beta range — not a name that's broken down. He's using selective sentences from a report whose actual synthesis section undercuts his conclusion.

On "laggard vs. LITE" — this is relative noise dressed as fundamental signal¶

Percentage moves on individual rally days are driven by float, short interest, options positioning, and sector rotation flows — not by a referendum on whose photonics IP is better. COHR is still up 59% YTD. It's still sitting on $415-500 analyst targets. No source in this entire debate — not the news report, not the fundamentals report — cites a single lost customer, canceled contract, or design win going to a competitor. "Capital preferred LITE on Tuesday" is trading color, not a moat thesis.

What this actually comes down to¶

The bear needs you to believe that a company delivering 29% revenue growth, margin expansion in every single quarter, and a swing from a $95.6M loss to $240.5M profit is somehow in a worse position than it was a year ago, because the cash flow statement hasn't caught up to the income statement yet. That's an unusual ask. Every hard-asset growth story — semis, cloud infrastructure, EV manufacturing — goes through exactly this phase, where capex outruns operating cash flow before the capacity monetizes. The market is pricing COHR at 20x forward earnings with a 0.92 PEG precisely because it's underwriting that transition, not because it's oblivious to the FCF numbers everyone in this debate has had in front of them the whole time.

At $279, in a name with an $11B TAM tailwind, a genuine product catalyst in PhotonLink, and a balance sheet that just self-funded its own capacity expansion without touching its debt capacity meaningfully — this is a name to own through the volatility, not avoid because of it. The chop the bear is pointing to is the market's uncertainty about timing, not about the destination. That's a gift for anyone with a time horizon longer than the next earnings print. Bull Analyst: # Bull Final Statement: Why COHR Remains a Buy at These Levels

Let's close this the right way — not by restating the same five bullet points a fourth time, but by putting the actual asymmetry of this decision in front of you clearly.

The bear demands a number I don't need to give him¶

The bear's entire closing hinges on one rhetorical trick: "when does FCF turn positive — give me a quarter." That's not how you evaluate a capacity-investment thesis in real time. Nobody gets a guided FCF inflection quarter mid-buildout — not Nvidia during its datacenter capex cycle, not TSMC during Arizona fab construction. What you get instead are the leading indicators that precede cash flow inflection, and COHR has all of them, undisputed by the bear himself:

Revenue up 29% cumulative, accelerating for four straight quarters
Gross margin expanding every single quarter: 36.6% → 38.5%
Operating margin nearly doubling: 10.9% → 14.9%
Inventory building specifically to service backlog, not sitting unsold

If the bear wants to argue the capex cycle never bends, he needs to explain why margins are expanding through it. You don't get gross margin expansion of 190bps in a single quarter (37.7% → 38.5%) if pricing power and volume absorption aren't real. That's the tell he has no answer for.

The dilution "gotcha" — he's still confusing consequence with cause¶

The bear says I'm citing "the consequence of dilution as proof dilution wasn't a real cost." I never claimed dilution was free — I said it bought $1.85B in growth capital at terms that, in retrospect, look favorable. He wants to dismiss market cap growth as "the stock going up for other reasons," but he can't have it both ways: either the market is pricing COHR based on fundamentals (his own framing when he calls the multiple "priced for perfection") or it isn't. If the market is pricing fundamentals — which is exactly the mechanism his own PEG/PE argument relies on — then a market cap that's nearly doubled since the raise is direct evidence the capital was deployed into a story the market is validating, not punishing.

And on "cash on hand declining $1.59B → $1.16B" — yes, because capex hit $562.9M that quarter. That's the plan working, not the plan failing. A company sitting on $1.16B cash, a 2.43x current ratio, and total debt that's grown less than 3% over three quarters ($3.43B → $3.54B) while funding a 5x capex ramp is not a company running out of runway. It's a company that raised capital specifically sized to the buildout it disclosed.

Insiders — the bear needs this argument to carry more weight than it can bear¶

Two years, zero insider buying above $104 — fine, that's the fact. But the bear is asking you to treat absence of buying as equivalent in signal strength to presence of selling. It isn't. Insiders overwhelmingly receive compensation in equity and sell on scheduled programs to diversify and cover tax obligations — that's true at every single high-growth tech company that's ever existed, including the ones that went on to 10x. The fundamentals report itself — which the bear keeps citing — characterizes the selling as "consistent with normal equity-comp diversification." He wants the "mildly cautionary" hedge to carry the whole argument while ignoring the sentence right next to it that undercuts his framing.

Technicals — he's still trying to have certainty without conviction¶

The bear's final move is "the MA break is a fact independent of ADX." Sure — but what to do with that fact is precisely what ADX tells you, and ADX at 6.34 says: don't act on it as a trend signal. He calls this "disconfirmation of buy-the-dip," but that's just relabeling "no signal" as "bearish signal" when it's convenient. The report's own synthesis is unambiguous: "no high-conviction reversal or breakdown signal yet." RSI at 45, z-scores unstretched, price $23 above the lower Bollinger Band. This is a stock in a wide range on a high-beta name — not a broken chart. A -5.5% day happens regularly in a name with a 2.10 beta and a $20 ATR; treating it as a verdict is exactly the overreaction the technical data argues against.

Peer rotation — revealed preference on a single day isn't a moat verdict¶

LITE outperforming COHR on specific catalyst days is a real observation, but the bear is stretching "capital rotated toward LITE on two sessions" into "COHR's competitive position is structurally inferior." That's not what differential single-day percentage moves tell you — they tell you about float, short interest, and options positioning that week. COHR is still up 59% YTD, still has zero disclosed customer losses, and still has $415-500 price targets from the same analyst community the bear wants to trust on everything else. If Wall Street believed COHR was losing the PhotonLink race to MACOM or GlobalFoundries, those targets wouldn't be sitting 40-80% above the current price.

Bottom line¶

Every fact is agreed. What's in dispute is interpretation, and the interpretation that fits all the evidence — not just the cash flow statement in isolation — is this: COHR is in the capital-intensive middle innings of a demand-driven capacity buildout, with margins already expanding, a well-capitalized balance sheet, a real product catalyst tied to an $11B TAM, and a valuation (20x forward, 0.92 PEG) that reflects growth already underwritten by the market — not growth priced for perfection with no room for error.

The bear's case requires you to believe operating leverage this consistent, this many quarters in a row, is decoupled from the cash flow statement forever. I don't think that's a bet the data supports. I think it's a bet that the bear needs the FCF conversation to stay open indefinitely because the operating story has already been won.

At $279, with a 200-day MA at $286.59 sitting just overhead and a stock that's proven it can round-trip from the $220s to the $350s and back inside of four months, this is a name to own into the next earnings print — not a name to abandon because one volatile session broke three moving averages that a 6.34 ADX tells you not to trust in the first place. Bull Analyst: # Bull Final Statement: This Is a Buy, and the Bear's Case Depends on You Ignoring Why

We've now gone six rounds, and the bear has spent every single one recycling the same five talking points with slightly different phrasing. That's not a sign of a deepening case — it's a sign the case was fully stated in round one and has nowhere new to go. Let me close this the way it should be closed: by showing you what actually determines whether COHR is a buy at $279, and why the bear's framework gets it backwards.

The real question isn't "when does FCF turn" — it's "is the demand real"¶

The bear keeps demanding a guided FCF inflection quarter as if that's the only valid form of evidence. But think about what that standard actually asks for: it asks you to wait until the company has already converted the capex into cash-generating capacity — which means waiting until the stock has already re-rated on that confirmation. That's not risk management, that's asking to buy the story after the market has already paid up for the certainty.

What we do have, undisputed by the bear across six rounds: - Revenue accelerating for four straight quarters, +29% cumulative - Gross margin expanding every single quarter (36.6% → 38.5%) - Operating margin nearly doubling (10.9% → 14.9%) - Inventory building specifically against backlog in a company that just launched PhotonLink with active customer engagements

You do not get 190bps of sequential gross margin expansion by accident, and you don't get it in a business that's losing pricing power to competitive pressure. The bear has never once explained the margin trajectory — he's just repeated "the FCF curve is accelerating" as if that fact alone invalidates every other fact in the report. It doesn't. It means capex is front-loaded relative to revenue capture, which is precisely what you'd expect from a company that just 5x'd its quarterly capex to build capacity for a market Citi says triples to $11B by 2030.

Dilution: he's arguing about the past, I'm pointing at the balance sheet today¶

The bear's final move was to say LITE re-rated "without diluting shareholders 22%," as if that's a knockdown. But LITE also didn't raise $1.85B to fund a 5x capex expansion — it's a smaller, less capital-intensive business making a different bet. Comparing dilution in isolation, without comparing what each company is building toward, isn't analysis — it's cherry-picking a single metric that looks bad standalone.

Here's what actually matters: COHR sits on a 2.43x current ratio, $10.9B in equity, $1.16B in cash, and total debt that's grown less than 3% over three quarters while funding a capacity buildout most companies would need to lever up significantly to finance. The bear calls cash declining from $1.59B to $1.16B a warning sign — I call it a company spending $562.9M on capex in a single quarter without touching its debt capacity in any meaningful way. If COHR were in the distress scenario the bear keeps implying, you'd see leverage climbing, not equity outpacing liabilities the way it has.

Insiders: the bear needs silence to mean something it doesn't¶

Six rounds in, and the bear's insider argument still rests entirely on absence of buying — not evidence of distrust, evidence of nothing happening. He wants "zero purchases above $104" to carry the same evidentiary weight as active, informed selling into bad news. It doesn't, and his own source says so explicitly: routine diversification, not a fundamental signal. Executives at high-growth tech companies overwhelmingly receive comp in equity and sell on programmed schedules — that's true of literally every high-multiple grower that's ever compounded for years afterward. If the bear had accelerating sale volume or unscheduled dumps timed to bad news, that would be a real signal. He has neither. He has a template.

The technical break: he still can't resolve his own contradiction¶

I'll say this one final time because he's never actually answered it: ADX at 6.34 means there is no confirmed trend. The bear wants credit for treating the MA break as "a fact independent of ADX" while simultaneously treating the MACD cross and moving-average violation as reasons to stay bearish. You cannot use "no signal confirmed" to justify caution on the upside while treating the same unconfirmed signal as meaningful on the downside. The report's own synthesis says it plainly: "no high-conviction reversal or breakdown signal yet." RSI at 45, not oversold. Z-scores unstretched at every timeframe. Price still $23 above the lower Bollinger Band. This is a 2.10-beta stock doing what 2.10-beta stocks do on a $20 ATR — not a broken thesis.

Peer rotation: single-session percentage moves aren't a verdict on competitive moat¶

The bear leans hard on "second-best performer in a five-name peer group on catalyst days" as if that settles the competitive question. It doesn't. Percentage moves on any given trading day are driven by float, short interest, options positioning, and where momentum funds happen to rotate that week — not by which company has the stronger photonics IP or better customer pipeline. Zero sources in this entire debate — not news, not fundamentals, not sentiment — cite a single lost customer, canceled contract, or design win going to MACOM or GlobalFoundries. The bear is reading tape noise as fundamental signal because he doesn't have an actual fundamental data point to point to.

What this debate actually comes down to¶

Strip away six rounds of back-and-forth and here's the asymmetry:

The bull case rests on hard, undisputed operating data — accelerating revenue, expanding margins every quarter, a real product catalyst tied to an $11B TAM, and a balance sheet strong enough to fund the buildout without meaningful leverage increase — at a forward multiple (20x, 0.92 PEG) that is already discounting real growth, not perfection.

The bear case rests entirely on reframing the consequence of a capacity-investment phase — negative FCF, dilution, no insider buying, one volatile session — as evidence the thesis is broken, without ever engaging with why the operating metrics are improving as consistently as they are. He's had six rounds to explain the gross margin expansion and hasn't touched it once, because it's the fact that doesn't fit his framework.

At $279, with the stock down from $440 highs, sitting on $415-500 analyst targets, backed by a company executing one of the cleanest operating turnarounds in tech, funded through a demand-driven capacity buildout rather than distress financing — this is a name to own through the volatility, not avoid because the cash flow statement hasn't caught up to the income statement yet. That gap is the opportunity, not the risk. The bear wants confirmation before conviction. I'd rather own the growth before the market fully prices the confirmation he's waiting for.

Bear Researcher¶

Bear Analyst: # Bear Case for COHR (Coherent Corp.)

The bull has built a compelling-sounding narrative, but let's be honest about what's actually happening here: this is a story stock trading on a forward PE of 20x and PEG of 0.92 that assumes flawless execution, funded by burning $650M in trailing free cash flow, in a stock that just broke down through every major moving average in a single session. Let's take this apart piece by piece.

1. The "acceleration" narrative ignores where the earnings quality is actually coming from¶

Yes, revenue grew sequentially for four quarters. But look closer at the Jun-26 quarter the bull is leaning on hardest: operating cash flow was negative $93.8M in the prior quarter (Mar-26) despite $191.4M of reported net income. That's a massive gap between what's being reported on the income statement and what's actually landing in the bank. And the fundamentals report explicitly flags that the latest quarter's net income included -$50.4M in restructuring/non-operating items netting into the number. This isn't a clean operating leverage story — it's a business where the P&L and the cash register are telling different tales, and the bull is citing the P&L exclusively.

2. Forward PE of 20x and PEG of 0.92 is not "cheap" — it's a bet with zero margin for error¶

A sub-1 PEG only looks attractive if you trust the forward estimates completely. This is a company that: - Just 12 months ago posted a net loss of -$95.6M - Has FCF that's gotten worse every single quarter (-$58M → -$96M → -$383M → -$493M) - Trades at 68x trailing earnings and 5x book value

That's not "growth at a reasonable price" — that's the market pricing in a specific, aggressive earnings trajectory with a beta of 2.10. If PhotonLink ramp timing slips even one quarter, or if the next print shows margin deceleration instead of expansion, that forward multiple re-rates violently in both directions. High beta cuts both ways, and right now the chart is showing you exactly which direction it's cutting.

3. Let's talk about that "self-funding" capex story — because the numbers don't support "self-funding" at all¶

The bull says COHR is "self-funding a capacity buildout." That's simply not what the cash flow statement shows. TTM free cash flow is -$650M and deteriorating each quarter. The company didn't fund this capex cycle from operations — it funded it with a $1.85B financing raise in March, which per the balance sheet data was tied to preferred-to-common conversion and share issuance (shares outstanding jumped from ~173.7M to ~212.3M). That's dilution, not self-funding. And critically: that cash raise is a one-time event. If capex continues at $500M+/quarter and OCF stays choppy-to-negative, what happens when that raised cash runs down? Another raise, more dilution, or a capex pullback that undercuts the growth story. None of those are good outcomes, and the bull glossed right past this.

Add to that: inventory is up 58% in three quarters to $2.58B. The bull frames this as "servicing a backlog." Maybe. But inventory builds ahead of confirmed demand are exactly what precede write-downs when demand normalizes or a competitor undercuts on price — and we have direct evidence of rising competitive intensity (more on that below).

4. Insiders aren't buying this story at these prices — and that matters¶

Across two years of Form 4 filings, there have been exactly two open-market insider buys, both tiny (500 shares each), both back near the 52-week low around $103. Since the stock tripled, it's been wall-to-wall selling — CFO, CTO, directors, officers, all distributing into strength. And Bain Capital, a >10% strategic holder, already dumped 7.5 million shares for over a billion dollars. The bull will say "that was at $143, stock's since doubled" — but that only proves Bain got out early and cheap relative to today, which is exactly the kind of information asymmetry retail should respect, not dismiss. People closest to the business, with the best visibility into whether PhotonLink revenue actually materializes on schedule, are not putting a single dollar of their own money into this stock at $270-320. That's a signal, not noise.

5. The bull's own technical report is far more bearish than he's letting on¶

The bull wants to frame today's -5.5% drop and ADX-near-zero as "no confirmed trend, so nobody can claim anything." That's a convenient half-truth. Here's what actually happened: price broke below the 10 EMA, 50 SMA, AND 200 SMA simultaneously in one session — after spending the prior week trading above the 200 SMA. That's a meaningful technical deterioration, not "chop is neutral." Yes, ADX is low, meaning the magnitude of conviction behind the move isn't confirmed yet — but that's an argument for staying on the sidelines, not for buying the dip. MACD also just crossed bearish after a brief bounce. RSI at 45 sitting mid-range after a 5.5% drop means there's real room to fall further before any oversold bounce thesis even kicks in. The bull calls this "a gift." I call it a stock that can't hold a trend in either direction, run by a company that hasn't turned FCF positive, trading at a premium multiple.

6. "Laggard vs. LITE" isn't a bullish reframe — it's a market telling you something¶

The bull spins underperformance versus Lumentum as "re-rating room." But markets are usually pretty good at relative pricing within a peer group that all has access to the same TAM story. If COHR were truly best-positioned to capture the $11B optical TAM, why is capital consistently preferring Lumentum on every rally day — 10% vs. 6.9%, and again with Corning/AAOI outrunning COHR? The news report explicitly notes this is not a uniform sector beta move — capital is differentiating among names, and it's differentiating away from COHR. Competitive intensity is rising too: MACOM's 3.2T optical chipset launch and GlobalFoundries' SMART Photonics partnership are direct evidence that COHR's photonics IP moat is not uncontested. PhotonLink is a slide deck and "customer engagements underway" — vague, unconfirmed, ramp guided vaguely to "late 2026." Competitors are shipping product now.

7. Macro and geopolitical risk is asymmetric against COHR specifically¶

The news report flags that the entire rally leg has coincided with falling bond yields — this stock's move is rate-sensitive, not fundamentals-driven in the short run. With prediction markets pricing 96% odds of zero Fed cuts in 2026, there is no rate-relief tailwind coming to bail out a multiple-compression scenario. Meanwhile, the Trump-Xi meeting and bipartisan China-transceiver legislation represent real, binary supply-chain risk for a company with a global, China-touching manufacturing footprint — the bull cites the China angle only as a tailwind (non-Chinese supplier advantage) while ignoring the report's own framing that the U.S. "can't have it both ways" on speed of AI buildout versus supply chain security.

Bottom line: COHR is a high-beta (2.10), richly-valued-on-trailing-basis (68x PE) turnaround story that has not yet proven it can generate cash — FCF is negative and worsening every single quarter, funded by dilutive capital raises rather than operations. Insiders aren't buying at these levels, the company is structurally underperforming its closest peer despite an identical TAM narrative, competitive threats are intensifying, and the chart just broke down through every key moving average on elevated volatility. The bull's entire case rests on trusting that PhotonLink ramps on schedule and that forward estimates hold — that's a lot of unconfirmed assumptions stacked on top of a stock that can't even establish a confirmed trend in either direction. This is a name to watch for confirmation, not to chase into a technical breakdown with a cash-burning balance sheet behind it. Bear Analyst: # Bear Closing Argument: The Bull's Rebuttal Confirms Everything I Said

The bull's rebuttal is a masterclass in reframing every red flag as a green one without actually engaging with the math. Let's finish this.

1. "Every capacity buildout looks like this" — no, they don't all look like THIS¶

The bull invokes Nvidia, TSMC, Micron as precedent for cash-burn-during-growth. Fine — but those companies' FCF craters were typically short-lived and clearly bounded, with visible order backlogs and disclosed capacity utilization metrics. COHR's FCF trajectory is -$58M → -$96M → -$383M → -$493M. That's not a one-quarter dip during a fab ramp — that's four consecutive quarters of acceleration in the wrong direction, with TTM FCF now at -$650M. The bull wants credit for "this is temporary" without a single data point showing when it stops being temporary. Management hasn't guided to a specific FCF inflection quarter. "Trust the pattern from other companies" is not the same as "trust this company's numbers," and the bear case doesn't require proving PhotonLink fails — it just requires pointing out that nobody has shown you the exit ramp from this burn rate.

And on the restructuring charge — I didn't cherry-pick it to attack operating income, I cited it to show that "swing from -$95.6M loss to +$240.5M profit" isn't a clean apples-to-apples operating comparison the way the bull's headline number implies. That's a fair caveat on earnings quality, not noise.

2. Dilution "bought $1.85B in growth capital" — bull is now arguing FOR my point¶

Watch what just happened: the bull conceded dilution, then argued it's fine because "market cap grew from $30B to $55B" over the same window. That's circular — market cap growing doesn't validate that the capital raise was efficient, it just means the stock went up for other reasons (AI sentiment, sector beta). You can't use the very re-rating that's under debate as proof the dilution was a smart trade. The actual question is: at $500M+/quarter capex with OCF still choppy-to-negative, is $1.85B enough runway, or is another raise coming? The bull has no answer to that, because there isn't one in the data. Net debt ticked back UP from $1.60B to $2.06B in the most recent quarter, which means the raise is already being consumed, not banked.

3. Insider selling — the bull can't have it both ways either¶

The bull says routine 10b5-1 selling "applies to every winner" — fine, that's a reasonable general point. But the bull conveniently ignores the specific detail I raised: CEO James Anderson bought a grand total of 1,000 shares, ever, both times near the 52-week low around $103. In two years of filings, at a stock that's now 3x higher, there is zero fresh conviction buying from anyone at these prices. If this were truly a 20x-forward-PE bargain with a $500 price target in sight, you'd expect at least one insider to step in with a real purchase, not just programmatic disposal. The bull's own source — the fundamentals report — calls this "a mildly cautionary signal for near-term entry." I'm not inventing that language; I'm reading it back to you.

4. Technicals — the bull is quoting my own report to dodge the point I actually made¶

I never said ADX proves a confirmed downtrend. I said: price broke below the 10 EMA, 50 SMA, AND 200 SMA in a single session, after a week spent above the 200 SMA. That's a fact, not an interpretation. Low ADX means the move lacks confirmed momentum — it does NOT mean the move didn't happen or doesn't matter. The bull's argument amounts to "since nothing is confirmed, assume it goes up." That's exactly backwards for risk management: when trend confirmation is absent, you don't lean into a fresh breakdown with a stock that's already flashing negative FCF and no insider buying — you wait. The bull calls a -5.5% day "Tuesday." Fine — then it's equally "Tuesday" when I point out that Tuesday just cost the stock its 200-day support. You don't get to dismiss the drop's significance and simultaneously claim the dip is "a gift" — pick one.

5. "COHR hasn't lost a customer to competitors" — that's not the bar¶

The bull says competitive launches from MACOM and GlobalFoundries just prove the market is growing. Maybe — but the report explicitly states capital is differentiating among names, not moving as a sector basket — Lumentum +10% vs. COHR +6.9% on the same rally day, again on another day 4% vs. higher moves from Corning/AAOI. If COHR had the structurally superior moat the bull claims, it wouldn't be serially the second-best performer in its own five-name peer group during every single upside catalyst day. You don't need a lost customer disclosed in an 8-K to see relative capital allocation happening in real time on the tape.

6. Macro — "no rate tailwind needed" cuts against the bull, not for him¶

The bull spins 96% odds of zero Fed cuts as "the rally doesn't need rate relief." But that's precisely the problem: it means there's no cushion if AI-capex sentiment even pauses. A beta-2.10 name that rallied on falling yields Sept 25 and sold off hard three days later has demonstrated exactly the rate-sensitivity I flagged — the bull just wants to call it a feature when it's a risk multiplier. And the Trump-Xi meeting, bipartisan transceiver legislation, and China supply-chain exposure remain unaddressed binary risks that the bull skips past every time.

Bottom Line¶

Strip out the bull's reframing and here's what remains undisputed, even by the bull's own rebuttal:

FCF has worsened for four straight quarters to -$493M/quarter, TTM -$650M — the bull has no answer for when this turns, only faith that it will.
Dilution happened (22% share increase) and net debt is already climbing back up post-raise — the "one-time capital solves everything" story is already showing cracks one quarter later.
Zero insider buying at any price above $104 in two years, flagged as cautionary in the bull's own source document.
A same-day break below all three major moving averages, in a stock that's a confirmed underperformer against its closest peer on every catalyst day.
A trailing PE of 68x and forward estimates that require flawless, on-schedule execution of a product (PhotonLink) that is still just "customer engagements underway," competing against MACOM and GlobalFoundries products that are already shipping.

This is a stock priced for perfection, run by a company that hasn't generated a dollar of free cash flow in over a year, where the people with the best information are selling into every rally and buying none of the dips. The bull's whole case is "trust the trajectory." Mine is simpler: wait for the cash flow to confirm the trajectory before paying 20x forward earnings on a name that just broke technical support. That's not fear — that's discipline the bull hasn't earned the right to skip. Bear Analyst: # Bear Final Rebuttal: The Bull Never Answered the Question That Matters

The bull's closing statement is longer than his opening, restates the same five points a third time, and still hasn't answered the one question that determines whether this stock is investable at 20x forward earnings: when does the cash flow turn? Not "it will because Nvidia's did." Not "trust the pattern." An actual number, an actual quarter. He doesn't have one. Let's close this out.

1. "Physics of manufacturing" is doing a lot of work to avoid a simple fact¶

The bull says capex-before-revenue is universal in hard-asset businesses, so criticizing it is unfair. Fine in the abstract — but he keeps skipping the specific shape of COHR's burn: -$58M → -$96M → -$383M → -$493M, four straight quarters of acceleration, with no guided inflection point. That's not "temporarily negative during a build." That's a burn rate that has grown roughly 8.5x in a year with management offering zero forward FCF guidance in anything cited in this debate. If this were TSMC-style disciplined capacity planning, you'd expect the burn to stabilize or narrow as new capacity comes online in phases. Instead it's still accelerating. The bull is asking you to underwrite the shape of a curve that hasn't bent yet.

2. The equity math the bull just presented actually proves my point¶

Look closely at what he did in this final statement: he cited total debt "barely moved" ($3.43B → $3.54B) and leaned on equity growth ($8.3B → $10.9B) as evidence of balance sheet strength. But he's conflating accounting equity growth from a capital raise and preferred conversion with organic financial strength. Equity went up because COHR issued 38.6 million new shares and converted preferred stock — that's the dilution event itself showing up as an equity increase, not a separate data point proving the raise was smart. He's citing the consequence of dilution as proof dilution wasn't a real cost. And net debt still ticked up $460M quarter-over-quarter post-raise, with cash on hand declining from $1.59B to $1.16B in the same period. The $1.85B cushion is already 25%+ depleted in the very next quarter, against a capex run-rate of $500M+/quarter. Do that math forward: at this burn rate, that cushion doesn't survive fiscal 2027 without either OCF turning sharply positive or another raise. Neither is confirmed.

3. On insiders — the bull's "trading windows" explanation doesn't survive contact with two years of data¶

He says executives "don't typically make large discretionary purchases into any price level." But that's not what I'm asking for — I'm asking why, across a company with dozens of officers and directors and two full years of filings, not one single person has made even a token open-market purchase anywhere north of $104. Compare that to the volume and consistency of selling — DiGirolomo, Skaggs, Xia, Luther, Eng, Corasanti, Neal-Graves, Beard, Bain Capital at $1B+ — a roster of essentially every insider with visibility into whether PhotonLink revenue is actually tracking to plan. The bull's own source calls the absence of buying "a mildly cautionary signal for near-term entry." He wants to argue with his own analyst. I'll just read the document.

4. Technicals — he still hasn't resolved his own contradiction, he's just restated it more confidently¶

The bull says "pick a standard" as if that settles it in his favor. Here's the standard, applied consistently: low ADX means don't trust the strength of a signal, not that the signal didn't occur. The price cross below all three moving averages is a fact of price, independent of ADX. ADX tells you how much weight to put on it as a continuation signal — it doesn't erase it. My position has been consistent the entire debate: this is not confirmation to short, it's disconfirmation of the bull's "buy the dip, it's a gift" framing. You don't lean into fresh weakness with negative FCF, no insider buying, and a laggard-vs-peer tape. That's not indiscipline — that's exactly the caution his own technical report's risk framing (wide ATR, conservative sizing) recommends, which the bull is asking you to ignore in favor of "gift" language his own source never uses.

5. "No lost customer disclosed" is a strawman — the tape already told you what you need to know¶

The bull keeps demanding an 8-K-level disclosure of lost business before he'll accept relative underperformance as meaningful. That standard doesn't exist in real-time investing — by the time it's in an 8-K, the stock's already repriced. What we do have, cross-validated by both the news report and StockTwits independently: COHR is the second-best performer in its own five-name peer group on every single catalyst day cited in this debate — 6.9% vs. LITE's 10%, 4% vs. Corning/AAOI's higher moves. That's not noise from one data point; it's a pattern across multiple sessions from multiple sources. Capital allocators with real-time information are choosing LITE over COHR repeatedly. That's a revealed preference, and revealed preference from professional capital is a better signal than a slide deck describing "customer engagements underway" for a product that hasn't shipped a dollar of revenue yet.

6. Macro — the bull's "feature not bug" framing ignores the asymmetry¶

He says the rally not needing rate cuts is bullish because it proves fundamentals are driving it. But flip it the other way: it means COHR's 59% YTD move happened almost entirely on AI-capex sentiment and falling yields on specific days (explicitly noted: rallied Sept 25 on falling yields, sold off hard three sessions later) — with zero cushion from a dovish Fed if that sentiment even pauses. A beta-2.10 name with no rate relief coming, 96% odds of zero cuts priced in, and binary Trump-Xi/China-transceiver legislation risk sitting unresolved is a stock with asymmetric downside relative to a fully-priced-for-perfection forward multiple. The bull never actually addressed the China/geopolitical risk in his final statement at all — he just dropped that thread entirely because he doesn't have a response to it.

The Actual Decision In Front of You¶

Every fact in this debate is agreed upon by both sides. The disagreement is about what to do with a stock that has:

TTM free cash flow of -$650M, accelerating in the wrong direction for four straight quarters, with no company-guided inflection point
22% share dilution in the last two quarters, with the raised capital already being drawn down faster than it's being replenished by operations
Zero insider buying above $104 in two years, explicitly flagged as cautionary by the company's own fundamentals
A fresh break below all three major moving averages, in a stock that is the demonstrated laggard in its own peer group on every recent catalyst day
A trailing PE of 68x and a forward multiple that requires PhotonLink to ramp exactly on schedule, against competitors (MACOM, GlobalFoundries) that are already shipping product

The bull's entire counter to every one of these points has been some version of "trust the trajectory" or "the market cap growth proves it." That's not an answer to risk management — that's the exact reasoning that turns a good company into an expensive mistake when the first guide-down or missed ramp date hits a stock priced at 20x forward earnings with negative cash flow and no insider conviction behind it.

This is a name to watch from the sidelines until free cash flow actually inflects and the technical picture confirms a floor — not a name to buy into a same-day breakdown on a promise. Discipline here isn't fear. It's declining to pay a growth multiple for a company that hasn't yet proven it can fund its own growth. Bear Analyst: # Bear Final Statement: The Verdict Is In the Numbers the Bull Never Disputed

The bull has now given his closing argument twice, and both times he's done the same thing: reasserted the operating metrics as if repetition substitutes for addressing the cash mechanics. Let me deliver the actual closing case, because the decision in front of anyone reading this debate is straightforward once you strip away the framing battle.

The single question that decides this trade¶

Forget the rhetorical back-and-forth for a second. Here's the only question that matters at a 20x forward PE / 0.92 PEG: is the market's confidence in flawless forward execution justified by what the company has actually shown you in cash terms? The bull's answer, every single time, has been "trust the leading indicators — revenue and margins are expanding, cash flow will follow." My answer is: the leading indicators he's citing have been true for four straight quarters, and the cash flow situation has gotten worse, not better, in every one of those quarters. That's not a timing lag anymore. That's a trend.

-$58M → -$96M → -$383M → -$493M. If margin expansion were genuinely translating into operating leverage that funds itself, that curve should be flattening by now. It isn't. It's accelerating. The bull has no rebuttal to this shape — he just keeps restating that margins are expanding, as if that alone proves cash generation is coming. It doesn't. Gross margin expansion can coexist with deteriorating cash conversion when working capital (inventory +58%, receivables growth) and capex are consuming cash faster than the improved margin generates it. That's exactly what's happening here.

On the "physics of manufacturing" defense — the burden of proof never shifted¶

The bull says nobody gets a guided FCF inflection quarter mid-buildout, so demanding one is unfair. I never demanded certainty — I pointed out that the absence of any visible inflection, combined with an accelerating burn rate, is itself the risk. Compare that to how the bull wants this graded: he gets credit for "the leading indicators are there," but I don't get to flag that the lagging indicator — the one that actually determines whether shareholders get diluted again — is moving the wrong way, faster, each quarter. That's an asymmetric standard of evidence in his own favor, and it's exactly the kind of "trust the story" reasoning that turns hot names into expensive lessons.

Dilution — he still hasn't answered the actual math¶

The bull's newest formulation is that the $1.85B raise "bought growth capital at terms that look favorable in retrospect" because market cap nearly doubled since. I'll say this plainly: that's not evidence the capital raise was well-timed or well-priced — it's evidence the whole sector re-rated on AI sentiment, which lifted every optics name, COHR included. LITE didn't raise $1.85B and diluted shareholders 22% to get its re-rating, and it still outperformed COHR on every catalyst day cited in this debate. The dilution is a real, permanent cost — 38.6 million new shares, forever, splitting future earnings among a bigger denominator — and the bull's only defense is "but the stock went up anyway," which is not the same as "the dilution was efficiently deployed." Meanwhile cash on hand fell $1.59B → $1.16B in a single quarter against capex of $562.9M. Run that forward at the current run-rate and the cushion doesn't last two more quarters without either an OCF inflection that hasn't shown up yet, or another raise. The bull has never once, across five rounds of this debate, given a rebuttal to that specific arithmetic. He's given me balance sheet ratios (current ratio, equity growth) that describe today's snapshot, not tomorrow's trajectory at this burn rate.

Insiders — read the document, not the spin¶

I'm not asking you to treat programmatic selling as proof of fraud. I'm asking you to notice what the bull has to work around: two years, dozens of insiders with the best visibility into whether PhotonLink is tracking on schedule, and exactly zero dollars of fresh conviction buying above $104. Not one CFO, CTO, director, or officer has looked at $270-320 and decided it's a buying opportunity, while retail on StockTwits is citing $415-500 price targets as if that gap is free money sitting on the table. If the people closest to the order book believed that gap was real and imminent, you'd expect at least one discretionary purchase somewhere in two years of data. You got two 500-share token buys at the 52-week low and then silence through a 3x. That's not distress-level selling, but it is a real, documented, unrebutted absence of insider conviction at these valuations — and the bull's own cited source calls it "mildly cautionary." I'm not editorializing that language into existence.

The chart broke down — and the bull's "pick a standard" line cuts against him, not me¶

Let's be precise one final time: I have never claimed ADX proves trend continuation. I've said the opposite — low ADX means don't trust the strength of the signal. But the bull is using that same low-ADX read to justify buying a fresh breakdown below the 10 EMA, 50 SMA, and 200 SMA simultaneously — treating "no confirmed strength" as equivalent to "no risk." Those aren't the same thing. In an unconfirmed, choppy, high-ATR ($20/day) environment, with negative FCF, no insider buying, and demonstrated underperformance versus the closest peer, the correct posture is exactly what disciplined risk management says: wait for confirmation, don't front-run it. The bull is asking you to buy the uncertainty. I'm telling you uncertainty plus negative cash flow plus no insider conviction is not a "gift" — it's a stack of reasons to let someone else find out first whether $279 was the floor or a waypoint to $256.

Competitive positioning — the pattern is now cross-validated, not anecdotal¶

This isn't "one bad day." The news report and StockTwits independently documented the same phenomenon across multiple separate sessions: COHR is the second-best performer in its own five-name peer group on every catalyst day referenced in this entire debate — 6.9% vs. LITE's 10%, 4% vs. Corning/AAOI's better prints. Two independent sources, multiple sessions, same conclusion. Meanwhile MACOM has an actual shipping 3.2T optical chipset today, and GlobalFoundries has a live silicon photonics partnership — real product, real customers, right now — against COHR's PhotonLink, which remains "customer engagements underway" with a ramp vaguely guided to "late 2026." The bull's response is "no disclosed lost customer" — but by the time a lost customer shows up in an 8-K, the repricing has already happened. The tape is the leading indicator here, and the tape has been consistent.

What this debate actually established¶

Both sides agree on every fact. What's been tested across five rounds is whether the bull can explain away an accelerating FCF burn, ongoing dilution risk, zero insider conviction, a fresh technical breakdown, and persistent peer underperformance — using nothing but "trust the operating leverage." He's made the same argument five times because there's only one argument to make, and it doesn't engage with the compounding nature of the risk: this isn't five independent minor concerns, it's one coherent picture of a stock priced for perfection that hasn't yet proven it can fund its own growth, confirmed by insiders' actions, confirmed by relative peer capital flows, and now confirmed by price action breaking down on the exact day this debate is being had.

At 20x forward earnings, 68x trailing, with TTM FCF of -$650M and no guided path to positive, this is not a name to buy into a same-day breakdown on faith that the cash flow eventually catches up to the story. It's a name to let prove it — with an actual FCF inflection, a technical floor, or a single insider putting real money behind the thesis at these levels — before paying up for it. Until one of those three things happens, the risk-reward here is asymmetric to the downside, not the upside the bull keeps asserting. Bear Analyst: # Bear Closing Statement: The Bull Never Answered the Money Question

Seven rounds in, and here's what's remarkable: the bull's final statement doesn't contain a single new fact. It's the same five bullet points — revenue growth, margin expansion, balance sheet ratios, ADX skepticism, "no lost customer" — recycled with slightly punchier language. When a bull has to restate his opening thesis verbatim in his closing argument, that tells you something about how much ground has actually shifted in this debate. None has. Let me deliver the verdict.

The bull still won't engage with the shape of the FCF curve¶

I've asked seven times: explain why the burn rate is accelerating — $58M → $96M → $383M → $493M — rather than stabilizing as capacity comes online in phases. The bull's answer, every single time, is "margins are expanding, therefore cash flow will eventually follow." That's not a rebuttal to the acceleration — it's a non-sequitur. Margin expansion on the income statement and cash conversion are two different mechanisms. You can have gross margin climb 190bps sequentially while working capital (inventory +58% to $2.58B) and capex (+5x) consume cash faster than the improved margin generates it. That's not a hypothetical — that's literally what COHR's own cash flow statement shows, quarter after quarter, and the bull has had seven opportunities to explain why that curve bends and hasn't taken one of them.

"You're asking for certainty no growth stock provides" — no, I'm asking for the minimum evidence any capital allocator should require¶

The bull keeps reframing my ask as unreasonable — "nobody gets a guided FCF inflection quarter mid-buildout." Fine. I'm not asking for a promise. I'm asking for one data point that shows the burn decelerating, or one insider willing to put real money behind the thesis at these prices, or one quarter where the technical picture confirms a floor. Zero for three. That's not an unreasonable bar — that's the bare minimum before paying 20x forward earnings on a name that's already 68x trailing.

Dilution: the bull's newest defense actually concedes my argument¶

In this final round the bull says LITE "didn't raise $1.85B to fund a 5x capex expansion — it's a smaller, less capital-intensive business making a different bet." Think about what that sentence just admitted: COHR needed to dilute shareholders 22% and raise $1.85B externally to fund growth that LITE is apparently generating without doing so. That's not a defense of COHR's capital efficiency — that's an admission that COHR's growth is more capital-hungry, more dilutive, and more dependent on external financing than its closest comp, which also happens to be outperforming it on every catalyst day in this debate. The bull is trying to spin "we had to raise more external capital than our better-performing peer" as a point in COHR's favor. It isn't.

And the arithmetic I raised in round six is still sitting there unanswered: cash on hand fell $1.59B → $1.16B in one quarter against capex of $562.9M/quarter. Extend that run-rate and the $1.85B raise doesn't survive fiscal 2027 without an OCF inflection nobody has shown you yet, or another dilutive raise. The bull's response has been to cite the current ratio and equity growth — both snapshot metrics that describe today, not the trajectory of a shrinking cash cushion against an accelerating burn rate. He has never once run that math forward. I have, and it doesn't close.

Insiders: "silence isn't a signal" is contradicted by the bull's own source¶

The bull's final move is to say absence of buying is just "nothing happening," equivalent to zero signal. But his own cited fundamentals report explicitly characterizes this as "a mildly cautionary signal for near-term entry." I'm not inventing that language — it's sitting in the same document the bull has quoted all debate to support his bull case. He wants to use that report selectively: trust it on gross margin trends, trust it on balance sheet ratios, but discard its own explicit read on insider behavior the moment it's inconvenient. Two years, dozens of insiders, a stock that's tripled — and not one CFO, CTO, or director with visibility into whether PhotonLink is tracking to plan has bought a single share above $104. Compare that to the wall of programmatic selling — DiGirolomo, Skaggs, Xia, Luther, Eng, Corasanti, Neal-Graves, Beard, and Bain Capital's $1B+ exit. If the $415-500 price target gap were as obviously real as retail on StockTwits believes, that's an extraordinary amount of unclaimed value sitting on the table that nobody closest to the business wants to touch.

Technicals: the bull still hasn't resolved his own selective use of ADX¶

He wants ADX at 6.34 to invalidate the MA breakdown as a signal, while simultaneously not applying that same "no confirmed signal" logic to justify not buying the dip. Here's the honest way to read low ADX: it means neither side should be making high-conviction directional bets right now. That's my argument, not his. The bull is the one making the high-conviction call — "this is a gift, buy it" — in an environment his own cited report says shows no confirmed signal in either direction. Low conviction data supports staying out, not leaning in with size on a name that just lost its 200-day support, has negative FCF, and zero insider buying. I'm not claiming the breakdown is confirmed bearish. I'm claiming the bull's claim — that this is unambiguously a buying opportunity — is the one requiring evidence that doesn't exist.

Peer rotation: two independent sources, multiple sessions, same pattern¶

The bull dismisses this as "tape noise." But it's not one data point — it's a cross-validated pattern from two independent sources (the news report and StockTwits, developed separately) across multiple distinct trading sessions: 6.9% vs. LITE's 10%, and again with Corning/AAOI outperforming on another day. When professional capital repeatedly chooses to allocate to the peer with the identical TAM story and without the dilution, without the negative FCF trajectory, and without the insider silence, that revealed preference is telling you something the bull wants dismissed as "float and options positioning." Maybe some of it is. But it's happened enough times, across enough sessions, that treating it as pure noise requires ignoring your own risk framework.

What actually stands unrebutted after seven rounds¶

FCF burn has worsened for four consecutive quarters with no company-guided inflection point — the bull has never explained the acceleration, only asserted it will resolve itself.
22% dilution, with the bull's own final-round comparison to LITE inadvertently proving COHR needed more external capital to fund growth than its better-performing peer.
Zero insider buying above $104 in two years, explicitly flagged as "mildly cautionary" by the bull's own primary source.
A same-day break below all three major moving averages, in a stock that's the demonstrated laggard against its closest peer on every catalyst day, across two independent data sources.
Competitive intensity rising — MACOM shipping today, GlobalFoundries partnered and live — against a COHR product that remains "customer engagements underway" with a vague late-2026 ramp.

At 20x forward earnings and 68x trailing, on a stock with a 2.10 beta, priced for flawless execution of a product that hasn't shipped revenue yet, funded by dilution rather than operations, with the people who know the business best not buying a single share — this is not a name to chase into a fresh breakdown on faith. The bull's whole case, restated seven times now, is "trust the trajectory." My case has been consistent too: let the cash flow, the insiders, or the chart confirm the story before you pay up for it. None of the three has. That asymmetry — not fear, not stubbornness — is why this is a name to watch from the sidelines, not to own at $279.

Research Manager¶

Recommendation: Overweight

Rationale: I'm siding with the bull, but not by enough to justify a full Buy. The bull's best evidence is operating data that nobody disputed. Revenue went $1.58B → $2.05B over four accelerating quarters (+29%). Gross margin rose every quarter from 36.6% to 38.5%. Operating margin went from 10.9% to 14.9%. Net income swung from -$95.6M to +$240.5M. At 20x forward earnings with a PEG of 0.92, a company growing like this isn't priced for perfection. Margins widening while capex rose 5x is hard to explain unless demand and pricing are real, and the bear never gave a direct answer on that.

The bear's best point is cash. FCF went -$58M → -$96M → -$383M → -$493M (TTM -$650M). Inventory grew 58% while revenue grew 29%. Cash fell from $1.59B to $1.16B in one quarter. At a burn of roughly $490M a quarter, that is about 2–3 quarters of cushion unless operating cash flow improves. Another raise or more borrowing is a real possibility, and the 22% dilution already happened. The bull never ran that math forward. He also overstated his case in places: the latest quarter's gross margin gain was about 80bps, not 190bps, and 'self-funded' is wrong, since the buildout was paid for with equity.

Still, the risk here is dilution and timing, not survival. Net debt of about $2.06B is small next to a ~$55B market cap, and the current ratio is 2.43x. The bear's other points carry less weight. The insider argument rests on no one buying, not on unusual selling, and the source report calls it only 'mildly cautionary.' Trailing LITE on a couple of rally days is tape action, not proof of lost business. The chart break below the 10 EMA, 50 SMA and 200 SMA is real, but ADX is about 6, RSI is 45 and z-scores aren't stretched, so it tells us how to time entries, not which way to lean. The bear himself ends at 'watch from the sidelines,' not 'the thesis is broken.'

Net: the fundamentals favor the bull. The cash burn, the 2.10 beta and the weak chart argue for building the position gradually and keeping it below full size.

Gaps in the evidence: there's no backlog or order data to back up the claim that inventory is 'for backlog,' no FCF or capex guidance, and no earnings date. The $415–500 analyst targets come from StockTwits and aren't verified. The price history is inconsistent: '$440 highs' in one place, a $220s–$350s range in another.

Strategic Actions: 1) Starter position: about 40% of a standard allocation near the current ~$279. The high beta (2.10) and ~$20 ATR mean the full target should be about 75% of standard, not 100%. 2) Add #1 (+20%): on a daily close back above the 200-day MA (~$286.59) with volume above average and MACD turning back up. Don't add while price sits under all three moving averages. 3) Add #2 (+15%, up to the 75% cap): only after the next earnings report shows at least one of these: FCF burn narrowing from -$493M, operating cash flow clearly rising, or inventory growing slower than revenue. Gross margin must also hold at 38% or better. 4) Risk control: the lower Bollinger Band (~$256) is the first line. Exit the starter on a daily close below ~$250 (about one ATR below that band). Reassess instead of averaging down. 5) Downgrade to Hold/Underweight if any of these happen: gross margin falls sequentially, FCF burn widens again with flat operating cash flow, another equity raise or preferred issuance, the PhotonLink ramp slips past late 2026, or China transceiver legislation directly restricts COHR's supply chain. 6) Watch closely: cash balance against the ~$490M/quarter burn, whether borrowing is used instead of issuing shares, how COHR trades against LITE on sector catalyst days, and any insider buying above $104, which would count as a meaningful positive. 7) Don't chase gap-ups into the $320s–$350s before cash flow confirms the story. Use the wide trading range to buy on pullbacks.

III. Trading Team Plan¶

Trader¶

Action: Buy

Reasoning: Research plan is Overweight/bullish, grounded in strong revenue/margin trends and a reasonable valuation (20x fwd, PEG 0.92), against a cash-burn/dilution risk that is a timing/survival-cushion concern rather than a thesis-breaker. Technicals confirm this is a starter-size, not full-size, entry: ADX ~6 signals no real trend (today's break below the 10 EMA/50 SMA/200 SMA is noise-prone), RSI 45 is neutral, and z-scores are unstretched, so there's no high-conviction reversal signal either way. Elevated ATR (~$20.42, 7.3% of price) and wide Bollinger Bands (256.16–324.65) argue for buying the current pullback in tranches rather than chasing strength, consistent with the plan's staged-add structure (200 SMA reclaim for add #1, post-earnings cash-flow confirmation for add #2).

Entry Price: 279.53

Stop Loss: 250.0

Position Sizing: Starter tranche ~40% of standard allocation at current price (~$279.53); cap total position at 75% of standard (not 100%) given 2.10 beta and ~$20 ATR. Add +20% on a daily close back above the 200 SMA (~$286.59) with above-average volume and MACD turning up; add final +15% only after next earnings confirms FCF burn narrowing, rising operating cash flow, or inventory growth slowing relative to revenue, with gross margin holding at 38%+. Do not average down below the stop.

FINAL TRANSACTION PROPOSAL: BUY

IV. Risk Management Team Decision¶

Aggressive Analyst¶

Aggressive Analyst: Let me open this debate the way it deserves to be opened, because the trader's plan here — buy COHR, starter tranche, staged adds — is actually the cautious version of what the data supports. I'm going to make the case for leaning in harder, and I'm going to pre-empt the objections I already know are coming.

Here's the setup: Coherent is sitting at the intersection of the single most powerful capital-spending cycle in a generation — AI datacenter optics — and a stock price that just got knocked down 5.5% in one session on what the technical report itself admits is a noise-prone, non-trending tape. ADX is 6.34. Let me say that again — 6.34. That is not a trend, that is not a breakdown, that is a coin flip dressed up as a chart pattern. When conservative and neutral voices point at "price broke below the 10 EMA, 50 SMA, and 200 SMA" as a bearish signal, they are citing a signal the report itself tells you to discount. You cannot have it both ways — you can't say "ADX confirms this is chop, ignore MA crossovers" and then turn around and use the MA crossover as your reason to wait. That's exactly the kind of overcautious, self-contradicting logic that causes people to miss the entry.

Now let's talk about what actually matters: the fundamentals underneath this "noise." Four straight quarters of sequential revenue acceleration, gross margin expanding from 36.6% to 38.5%, operating margin nearly doubling from 10.9% to 14.9%, and a net income swing from a $95.6 million loss a year ago to $240.5 million now. That is not a story that needs to wait for confirmation — that is a company already in the middle of proving the thesis. A forward PE of 20 with a PEG of 0.92 on that kind of trajectory is not an expensive stock, it's a mispriced one, especially with Citi calling for an $11 billion optical networking TAM by 2030 and PhotonLink customer engagements already underway ahead of a late-2026 revenue ramp. Retail is sitting there pointing at a $415 average price target and a Rosenblatt $500 reiteration against a $279 print. That's not chop-related frustration, that's a gap begging to be closed.

I know exactly what the conservative analyst is going to say next, so let me hit it now: free cash flow. TTM FCF of -$650 million, capex 5x'ing in four quarters, "not self-funding," "capital-intensity risk." Fine — but look at what's actually driving that number. This isn't cash bleeding out of a failing business model, it's $562 million of capex in a single quarter because they are building capacity to meet demand they already have contracts and engagements for. Companies in the steepest part of an AI infrastructure buildout are supposed to look like this. Nvidia's suppliers, the hyperscalers, everyone riding this wave has negative near-term FCF optics because they're all racing to build capacity before the demand window closes. Penalizing COHR for investing aggressively into a genuine $11 billion TAM is exactly the kind of conservatism that means you buy the stock at $420 after the capex has already converted to revenue, instead of at $279 while it's still being built. The company already raised $1.85 billion in financing to fund this and equity swelled from $8.3 billion to $10.9 billion — this is a funded growth phase, not a survival crisis. The trader's own reasoning gets this exactly right: it's a timing and cushion issue, not a thesis-breaker. I'd go further — it's not even that much of a cushion issue. Current ratio 2.43x, net debt actually declined from Dec-25 to Mar-26. This company has plenty of runway.

On insider selling — yes, executives have been selling into strength. That's what executives with concentrated equity comp do after a stock goes from $105 to $440. It would be far more alarming if they weren't diversifying at all. What I'd flag instead is that nobody's dumping in size at these levels relative to their total holdings, and Bain's big sale was at $143, less than half of where we are now — that's an old, stale data point being used to manufacture caution about today's price.

Now to the neutral case, which I suspect leans on "RSI is neutral at 45, z-scores aren't extreme, wait for confirmation." I'd push back hard on the idea that you need statistical extremity to act. Waiting for RSI to hit 30 or z-score to hit -2 means waiting for the crowd to already be panicking — at that point you're buying confirmation, not opportunity. The report itself says weekly z-score is already at -1.03, the mildly-oversold primary tier, on a stock whose institutional and retail narrative are both structurally bullish and whose only real headwind cited is "COHR is merely up 59% instead of up 120% like Lumentum." Being the laggard in a basket that's all going up is not a bear case, it's a rotation opportunity — capital chasing Lumentum's relative strength today rotates into COHR's relative value tomorrow, especially once PhotonLink customer wins start showing up in headlines.

And let's not undersell the setup this drop created. A name with a 2.10 beta getting hit on a no-trend, low-ADX day, sitting above the lower Bollinger Band with $23 of room before any real technical damage, RSI neutral rather than broken, MACD histogram still technically positive — this is precisely the environment where aggressive accounts get paid for having the conviction to buy the pullback instead of waiting for the all-clear that, by definition, only comes after the cheap price is gone.

So here's my case for going further than the plan as written: the 40% starter / 75% cap structure is fine as a floor, but I'd argue the add triggers are overly conservative — waiting for a 200 SMA reclaim AND above-average volume AND MACD turning up before adding tranche two stacks three confirmation signals on a stock the report already tells you is trendless. In a no-ADX regime, demanding trend confirmation before adding is asking a coin-flip indicator to tell you when to commit more capital to a fundamentally-driven thesis. I'd rather see the second tranche sized to the fundamental catalyst — PhotonLink customer disclosures, any pre-earnings commentary on capex normalizing — than purely technical triggers that this same report calls noise-prone.

Bottom line: this is a high-beta, high-growth name at a reasonable multiple, riding a real, multi-year AI infrastructure TAM expansion, currently mispriced relative to Street targets, having a garden-variety volatile pullback in a stock whose own trend indicator confirms there's no bearish trend to fear. The stop at $250 gives real room below the recent range low. The upside case — PhotonLink ramp, TAM expansion, margin trajectory continuing, multiple re-rating toward even a fraction of that $415 average target — dwarfs the downside being debated here. Buy it, size it aggressively within risk limits, and don't let a six-handle ADX reading talk you out of a $11 billion TAM story trading at 0.92 PEG. Aggressive Analyst: Good, both of you actually engaged the substance this time instead of just repeating talking points, so let me engage back — because I think you've both talked yourselves into a false symmetry that ends up costing the trader upside for no real risk reduction.

Let's start with the ADX "gotcha" since both of you independently landed on it like it's a checkmate. Here's the flaw in the "you can't discount the bearish MA signal but keep bullish conviction" framing: I'm not treating ADX as neutral between two technical signals. I'm treating it as evidence that the technical picture has no edge, full stop — bullish or bearish. That's exactly why my actual position sizing recommendation isn't "go to 100% on conviction," it's "keep the structure, size the second and third tranches off something that actually has signal content." The neutral analyst says this is "motivated reasoning with extra steps" — but think about what you're actually defending when you insist the 200 SMA reclaim plus volume plus MACD stack has to gate tranche two. You're defending three inputs from the same broken indicator family. If ADX 6.34 tells you MA crossovers and MACD are noise-prone right now, then a "200 SMA reclaim with above-average volume and MACD turning up" isn't a robust confirmation stack — it's three noisy dice rolled together and called triangulation. That's not more rigorous, it's the illusion of rigor. My point was never "abandon discipline," it was "don't dress up unreliable technicals as discipline while the actual fundamental catalysts — PhotonLink disclosures, capex commentary — go completely unweighted in the trigger design." The neutral analyst's compromise of a trend-based OCF check across two prints is actually much closer to what I was arguing for than to the conservative gate — that's a fundamental-data trigger, not a technical one. I'll take that. But let's be honest about what just happened: the "sensible middle ground" moved toward my side of the argument on the exact mechanism I was pushing.

Now, operating cash flow versus net income divergence — both of you are treating this like I ignored it. I didn't ignore it, I contextualized it, and the neutral analyst's own data undercuts the alarm. March OCF was -$93.8M. June OCF was +$69.46M. That's not an unexplained, worsening quality-of-earnings crisis — that's exactly the kind of single-quarter working-capital lumpiness you'd expect when inventory builds 58% ahead of a demand ramp you already have engagements for. You want to call that a "quality of earnings question buried in the margin numbers" — but gross margin and operating margin are GAAP line items expanding for four straight quarters. Restructuring charges netting to -$50.4M are below the operating line; they don't touch the 38.5% gross margin or the 14.9% operating margin, which are the actual evidence of pricing power and scale economics. You're trying to use a below-the-line item to cast doubt on above-the-line operating leverage that's been improving every single quarter regardless of one-time items. That's not a quality-of-earnings gap, that's just what happens when a company converts inventory into revenue with a lag.

On insider buying — conservative analyst, you conceded the selling is routine and then pivoted immediately to "but where's the buying." The neutral analyst already dismantled this cleanly: executives don't open-market buy after a stock has already run 3-4x, that's not a fundamental signal, it's a liquidity and tax-optics decision, and you're using its absence as a stand-in for a bear signal you don't actually have. I'd add — the CEO's two buys at $102-104 happened when the stock was unloved and cheap. That's literally the definition of buying conviction at value. Insiders aren't supposed to keep buying every ten points on the way to $440; if they did, that would actually be a red flag about their own portfolio concentration risk, not a green flag for you.

Geopolitics — I'll grant it's real, but let's be precise about what it actually implies for sizing rather than just gesturing at it. The IBD framing is "can't have both speed and security" — which cuts in COHR's favor if the outcome is restrictive on Chinese transceivers, because COHR is explicitly named as a non-Chinese alternative supplier that benefits from exactly that kind of policy. The conservative case wants to treat Trump-Xi as pure tail-risk-to-the-downside, when the specific legislative angle cited in this report is a subsidy to COHR's competitive position, not a threat to it. You can't just stack "geopolitics" as a generic scary word — the actual mechanism described here is more bullish than bearish for this specific name.

On the "laggard vs Lumentum" point — I want to push back harder on how both of you are reading this, because I think you're reading a rotation signal backwards. Ciena just got a 58% upside call from Evercore as an "AI bottleneck" thesis. Lumentum is up 12% in a month. That is not evidence the group is done running — that's evidence the group is in the early-to-middle stages of a multi-name re-rating, and COHR, with PEG 0.92 versus peers trading at a premium for the exact same TAM story, is the cheapest way to keep riding it. "Rotation risk" as a bear case for COHR only works if you think the AI optics trade itself is topping out. Nobody on this call is arguing that — Citi's $11B TAM call, the Google/Nvidia capex commentary, none of it is being disputed by either of you. If the sector thesis is intact and COHR is the laggard on valuation and price action within that sector, the higher-probability outcome is convergence, not permanent underperformance. You don't get to agree the sector story is real and then treat the cheapest name in the sector as the one to avoid.

Now, cash burn and the raise — I keep hearing "the equity is doing double duty as a financing vehicle" like that's inherently a problem. It's a problem if the capital isn't going to work. Here it very obviously is: capex went from $104M to $563M a quarter, inventory is up 58%, and both of those numbers describe a company building physical capacity to fulfill a demand signal it already has, ahead of a PhotonLink ramp its own management is calling out publicly. A $1.85B raise executed at a period of stock strength, with equity swelling to $10.9B against $2.06B of net debt and a 2.43x current ratio, is a company financing growth from a position of strength, not one financing survival from a position of weakness. You want a scarier version of this story to justify smaller size — the actual balance sheet doesn't support the scary version.

Here's my real answer to the neutral analyst's landing spot, because it's closer to reasonable than the conservative one and I want to engage it honestly rather than just claim victory. I actually think keeping the 200 SMA/volume trigger for tranche two is fine as a floor — I was never asking to remove all technical structure, I was asking not to let three unreliable-in-this-regime signals be the ONLY gate on committing more capital to a name with this improving a fundamental trajectory. Where I'd push further than even your revision: don't make PhotonLink customer disclosure an either/or replacement for the technical trigger, make it an accelerant — if a specific named customer win drops before the 200 SMA reclaims, that's real, fundamental, forward information the market hasn't priced yet, and waiting for price to catch up to news you already have is exactly the "buy confirmation instead of opportunity" mistake I flagged in my opening. Technical gate stays as a floor. Fundamental catalyst can pull the trigger early. That's not removing discipline, that's having two doors into the position instead of one, which is the correct structure for a name the report explicitly says is trading in a low-signal technical regime.

Bottom line, and I'll leave it here: nothing either of you said actually attacks the core asymmetry. Four quarters of accelerating revenue, margin expansion at every level above the one-time-items line, PEG under 1, a named $11B TAM with COHR-specific product news already shipping, a balance sheet that just got materially stronger, and a stock sitting $23 above its lower Bollinger Band after a single noisy, low-ADX, no-trend session. The downside scenarios you're both describing — chop continuing, FCF staying negative another quarter or two, a bad geopolitical headline — are real but bounded by the stop at $250. The upside scenario — PhotonLink converts, multiple re-rates even partway toward Street targets, capex converts to revenue on the timeline management is already guiding to — is not symmetric with that downside. That asymmetry is the entire case for buying the starter tranche now, keeping a real structure for adds, and not letting a coin-flip trend indicator or a generic macro checklist talk anyone into a smaller starting position than the fundamentals justify. Buy it. Aggressive Analyst: Good, let's finish this properly, because I actually think both of you just converged on my structure while pretending you didn't move.

Neutral analyst, let's start with you, because you did something interesting: you rejected my accelerant door, kept the trader's 40% starter, kept the 75% cap, kept both technical and fundamental gates roughly as designed — and then you added a capex-plateau freeze that is, functionally, exactly the kind of fundamental-data trigger I was arguing for all night. You just built it on the risk side instead of the reward side. I'm not going to pretend that's a loss for me. If quarterly capex can freeze adds regardless of what the technical gates say, you've already accepted the core premise I opened with: fundamental data deserves standing to override a low-ADX technical regime. You just applied it defensively instead of offensively. Fine — I'll take that mechanism and ask the obvious follow-up question you didn't answer: if capex data is good enough to freeze an add without ADX's permission, why isn't a named PhotonLink contract win good enough to accelerate one? You can't grant fundamental triggers veto power over technicals and then deny them entry power over technicals in the same plan. That's not principled, that's asymmetric caution — you're fine with fundamentals working against the position, just not for it.

And on the falsifiability critique you leveled at me — fair hit, I'll engage it honestly instead of dodging. You're right that "customer win headline" needs a harder edge. So let's put a harder edge on it right now instead of throwing the whole mechanism out: a named, dollar-quantified or unit-quantified PhotonLink customer disclosure in an 8-K, press release, or earnings call — not a vague "engagement underway" mention, an actual contracted commitment — is the trigger. That's falsifiable. That's adjudicable by anyone reading the same document. It's not me eyeballing a headline and vibing my way into more size. You rejected the mechanism because the first version of it was underspecified, not because the underlying logic was wrong. Tighten the definition, don't kill the door.

Conservative analyst, I want to go after your closing point directly because I think it actually reveals the exact asymmetry I've been naming all night. You said, and I'm going to repeat it because it's the tell: "the fundamentals story is real, I'm not disputing revenue acceleration or margin expansion... but this is the right size and right week to lean into that fact are two different questions, and only one has been answered tonight." Except — you just spent four rounds answering it, in the direction of "no," using a rotating cast of justifications: ADX first, then FCF, then insider silence, then geopolitics, then capex trajectory, then this week specifically because of Trump-Xi. Every single round the specific reason changes but the conclusion never does. That's not "letting the data decide," that's having a conclusion and auditioning arguments for it. I said this about the laggard framing being unfalsifiable — turns out the whole conservative case has the same shape. If COHR chops, that proves caution was right. If COHR rips, that proves the caution was "responsibly missed" but the thesis is "still intact for next time." There's no data print in this report that would make you say "okay, size up now." That should bother you as much as you claim the laggard argument should bother me.

And the neutral analyst already caught you on the 30% cut specifically — no outcome falsifies it, it's a one-way hedge against blame, not a risk-based number. You didn't actually contest that when you had the chance, you just moved on to OCF. So let's sit on it: you're proposing to under-size a starter position, in a name with four straight quarters of margin expansion and a sub-1 PEG, specifically because of a binary event that IBD itself frames as two-sided and that your own report shows has a plausible bullish resolution for COHR as a named alternative supplier. You're asking the trader to pay a certain cost — smaller position, less exposure to a real re-rating if PhotonLink or the summit outcome breaks well — to hedge an uncertain, symmetric risk. That's not risk management, that's negative expected value dressed up as prudence.

On OCF, you keep insisting two prints isn't a trend while telling me two-year-old $103 insider buys are stale — the neutral analyst already boxed you on the inconsistency and you didn't actually resolve it, you just reasserted TTM FCF is still negative. I know it's still negative. Nobody's disputing that number. What I'm disputing is the inference you're drawing from it — that negative TTM FCF in the middle of a capacity buildout, with equity at $10.9B, current ratio 2.43x, and net debt actually lower than it was in December, is evidence of fragility rather than evidence of a company executing a growth plan it's fully funded to execute. You want capex to "show a ceiling" before you'll relax — but a company management is telling the market, in public disclosures, is building toward a late-2026 PhotonLink ramp is not supposed to show a capex ceiling yet. Demanding a capex plateau before conviction is demanding the buildout be over before you'll buy in — at which point you're not buying the buildout, you're buying the harvest, three multiple turns higher.

Here's the actual synthesis I want to leave the trader with. Every legitimate risk raised tonight — capex trajectory, OCF quality, geopolitical binary, technical noise — has now been captured by an objective, falsifiable gate: the 200 SMA/volume trigger stays as the technical floor, the OCF-trend-plus-margin-floor gate handles cash-quality, and neutral's new capex freeze handles the one risk nobody had gated yet. That's a genuinely tighter plan than either the aggressive or the conservative opening tonight. Where I still push: don't shrink the starter below 40%, because none of tonight's stacked worries survived scrutiny as COHR-specific deterioration rather than generic macro anxiety or timeline mismatch between capex spend and capex payoff. And add the symmetric door — a hard-defined, quantified PhotonLink contract disclosure as an accelerant on tranche two, alongside the 200 SMA trigger, not instead of it. Two objective doors, not one door and one excuse.

40% starter, 75% cap, stop at $250, tranche two on 200 SMA reclaim plus volume OR a quantified PhotonLink contract disclosure, final tranche on OCF trend plus margin floor, capex freeze checkpoint intact as the neutral analyst proposed. That's the version that actually uses every real signal in this report instead of only the ones that argue for standing still.

FINAL TRANSACTION PROPOSAL: BUY Aggressive Analyst: Let me close this out, because I think the conservative analyst just spent an entire round proving my point while insisting she was refuting it, and I want to walk through exactly how.

Start with her falsifiability answer, since she actually engaged it honestly and deserves a direct response. She said: if the summit passes cleanly, I underperform, and the lesson is "use a tighter trigger next time." Listen to what that sentence actually concedes. She's not saying "the 30% cut was correct and here's the evidence." She's saying "the cut was a cost I'm willing to pay regardless of outcome." That's not a risk model, that's insurance bought against a scenario she herself can't price the probability of — and the neutral analyst already nailed this: a real risk-based response to a two-sided binary event is to adjust the stop or the holding period around the event, not to shrink the entry and then plan to size back up the moment the calendar clears. You don't manage event risk by taking a smaller bite of a good meal. You manage it by knowing when to put your fork down. The stop at $250 already does that job. Cutting the starter on top of an unchanged stop is double-charging the position for a risk the stop already covers.

Now the capex sequencing critique — I'll give her full credit, that was her best point tonight and the neutral analyst was right to adopt the fix. But watch what she did immediately after getting that concession: she tried to bootstrap it into a case for ALSO cutting the starter to 30%. Those are two different arguments. The capex-conditional haircut on tranche two is a precise, timing-correct answer to a precise, timing-correct problem — good capital gets deployed exactly when the data supports it, and less capital gets deployed when it doesn't. That mechanism working well is an argument FOR trusting the framework to handle risk at the point where it actually shows up, which is tranche two and beyond. It is not an argument for front-loading caution into tranche one, where none of tonight's stacked concerns — capex, OCF, insider silence — even apply yet, because tranche one isn't gated on any of those things resolving. She fixed the plumbing on floor two and then argued the foundation needs to be smaller. Those don't follow from each other.

On the OCF time-horizon defense — she says she's not being inconsistent, she's asking each data point to be relevant to the specific claim it supports. Fine, let's hold her to that standard on her own strongest data point: TTM free cash flow of -$650 million. That number is backward-looking across four quarters that include the worst capex ramp quarter in the company's history. By her own logic, a trailing-twelve-month aggregate that includes Sep-25's -$58M burn alongside Jun-26's -$493M burn is exactly as time-mismatched as citing a two-year-old insider buy — you're blending a calmer regime with the current one and calling it "the current picture." If Mar-26's negative OCF print is decision-relevant today, and Jun-26's positive rebound is only "one data point, not a trend" — then TTM FCF, which is even more backward-loaded with stale quarters, deserves the same discount she's applying to old insider buys. She can't selectively demand recency for the metric that supports caution while citing a trailing-twelve-month aggregate as her headline scary number. Pick the standard, apply it everywhere — including to the number she leads every single round with.

On the "stacking" defense — she says the multiplicity of concerns IS the finding, not evidence of fishing. I'd ask her to actually defend that claim instead of just asserting it, because here's the problem: every one of those legs, examined individually tonight, either got resolved in the bull's favor or got neutralized by the neutral analyst as generic rather than COHR-specific. ADX — no directional information either way, addressed by sizing structure, not entry size. FCF — explained by a demand-driven capex ramp with a funded balance sheet. Insider silence — the neutral analyst explicitly called this low-information given post-run liquidity dynamics. Geopolitics — two-sided per her own IBD citation, with the specific named legislative angle actually favoring COHR as a non-Chinese alternative. Laggard-vs-Lumentum — a valuation opportunity within a sector nobody disputes is intact. If you take five arguments, and four of them net out neutral-to-favorable on closer inspection and the fifth is a temporary two-sided calendar event, stacking them doesn't multiply the risk — it's supposed to average toward the true signal, which is: strong, accelerating, COHR-specific fundamentals with generic, temporary, mostly-priced macro noise around the edges. "Multiplicity of concerns" only works as an argument if the concerns are independent and each individually survives scrutiny. Half of these didn't survive scrutiny tonight — they got explained, not dismissed, explained — and she's still counting them as full weight in her stacking argument.

And on my accelerant door — she says a falsifiable trigger that still routes you into a volatility spike is a "better-dressed version of the same mistake." I'd flip that. The mistake isn't "buying into a move," the mistake is buying into a move with no underlying information edge. A stock gapping 8% on nothing — pure noise, exactly what today's ADX-6 session was — is genuinely dangerous to chase. A stock gapping on a quantified, named customer commitment that the market hasn't had 48 hours to fully digest is the textbook definition of an information edge showing up before price fully reflects it. Waiting for the 200 SMA to reclaim AFTER that kind of news is already public means you are explicitly choosing to pay a higher price for the same information, in exchange for exactly nothing — no risk reduction, because the news itself, not the moving average, is what changed the odds. I'll accept the neutral analyst's judgment that this door stays shut tonight for structural, discretion-based reasons — that's a fair, principled call on process grounds. But let's be clear that the reason it's shut is about avoiding subjective moment-of-decision discretion, not because the underlying logic of "material new information should be allowed to move a fundamentally-driven thesis" is wrong. It isn't wrong. It's just harder to systematize cleanly than the technical gates are, and I respect that the neutral analyst held that line on process rather than pretending the idea itself was bad.

Here's my actual bottom line, and it's the same one I opened with: nobody tonight produced a COHR-specific reason to under-fund the starter tranche. Four straight quarters of revenue acceleration. Margin expansion at every operating level. A sub-1 PEG against an $11 billion TAM that Citi, not COHR's own investor relations, is putting a number on. A balance sheet that raised capital from a position of strength, not weakness — equity up, net debt down quarter over quarter, current ratio north of 2.4x. A stop at $250 that already prices in the ATR, the beta, and the binary event risk this week. Every specific, falsifiable risk raised tonight — capex trajectory, cash-quality, technical noise — already has an objective gate built into this plan. What's left standing after four rounds is not a stacked case for caution. It's one temporary calendar concern dressed up as five separate ones, and a trader who lets that talk him into a smaller starter position is paying for insurance on a risk his stop loss already covers for free.

40% starter, 75% cap, $250 stop, tranche two on the 200 SMA reclaim with the capex-conditional haircut intact, final tranche on the two-print OCF-and-margin gate, capex freeze as backstop. That's the plan on the table, it prices every real risk raised tonight, and it doesn't ask the trader to pay twice for the same protection the stop already provides.

FINAL TRANSACTION PROPOSAL: BUY Aggressive Analyst: Let me close this out, because both the conservative and neutral analysts just delivered their final arguments, and I want to make sure the trader walks away seeing exactly where each of them is still wrong, not just where they sound reasonable.

Conservative analyst, your last round was your best rhetorical move of the night — the "every control fails the same hindsight test" argument against the neutral analyst — but it doesn't actually rescue your 30% number, and here's why. The stop, the technical gates, the capex freeze all share one property yours doesn't: they're triggered by data that updates. The stop fires on price. The 200 SMA gate fires on a close. The capex freeze fires on a specific dollar figure at the next print. Your 30% starter is not contingent on anything — it's a static haircut applied today, before the summit outcome, before the next print, before any of the data that would actually tell you whether the risk materialized. That's the difference between a control and a guess dressed as a control. A real risk control has an "off" switch built into its own definition. Yours doesn't — you said it yourself, you'd size back up "once the calendar clears," which means the 30% number was never actually about analyzing COHR-specific risk, it was a countdown timer wearing a risk-management costume.

And on the gap-through argument — I'll grant you found a real distinct failure mode tonight, credit where due, but watch what you did with it. You correctly identified that a stop doesn't protect against a gap. Then you used that correct insight to justify... a linear 25% reduction in dollar exposure. That's not a gap-risk-calibrated number, that's just your original number with a new coat of paint. If gap risk through a binary summit is the actual concern, the tool for that is exactly what the neutral analyst said: execution awareness, tighter time horizon around the event, maybe options collars if the desk has that capability — not an arbitrary haircut to a starter tranche that has nothing to do with the summit's actual probability distribution. You're solving a Tuesday-through-Thursday problem with a permanent-until-I-feel-better-about-it position size. Those don't match.

On the TTM FCF defense — I want to press this one more time because I don't think you actually closed the loop. You said TTM FCF is a "cumulative burn to date" claim, not a run-rate claim, so it's legitimately backward-looking by design. Fine, I'll accept that TTM is supposed to be backward-looking. But then you turn right around and use that same backward-looking number as the emotional headline of your closing argument — "the company just told the market it cannot fund its growth plan, and the gap has widened to $500 million in a single quarter since the raise." That's not a backward-looking claim anymore, that's you smuggling forward-looking alarm ("the gap hasn't closed") back into a number you just told me was purely retrospective. You can't have TTM FCF be "just describing the past" when I press you on the insider-buy inconsistency, and then have it be "proof the crisis is ongoing and unresolved" when you're building your closing case. Pick one job for that number.

Here's the thing both of you are missing in a shared way, and I want to name it plainly before I land this: you keep treating "unresolved risk" and "reason to under-size" as the same statement. They're not. Every single risk on this desk tonight — capex trajectory, OCF quality, geopolitical binary — already has an objective, falsifiable, forward-looking gate built into this plan. The capex freeze catches the capex risk. The two-print OCF-and-margin gate catches the cash-quality risk. The stop catches the price risk. What's left for the starter tranche to protect against, once all of those are built? Nothing that hasn't already been assigned its own control. Asking tranche one to also carry a discount for risks that tranches two, three, and the stop are already pricing is not stacking protection, it's double-billing the trade for the same insurance policy under different names.

Neutral analyst, I want to acknowledge you held the line well tonight on the accelerant door, and I'm not going to keep re-litigating it — you're right that the version narrow enough to be falsifiable is also narrow enough to be nearly useless, and the version broad enough to matter routes capital into a gap. I'll take that loss cleanly. But I want to flag one place where I think you underweighted your own logic: you said the capex freeze is different from my accelerant door because a freeze is "defensive, asymmetric-cost, fully recoverable" while an add is "offensive, harder to reverse." That's true as a general risk principle, but notice what it actually implies for sizing, not just for mechanism design — it implies that the starter tranche itself, sized appropriately, is the actual offensive commitment that deserves scrutiny, and everything after it is where the defensive controls do their work. Which is exactly why 40% and not higher is correct, and exactly why the conservative analyst's instinct to shrink further is solving a problem in the wrong place. You get one shot at pricing the initial commitment correctly — RSI neutral, z-scores unstretched, ADX with no directional edge — and every layer after that has a gate. That's not a coincidence, that's good architecture, and it's the plan on the table.

So let me leave the trader with the actual asymmetry one more time, cleanly, because four rounds of debate haven't dented it. This is a company with four consecutive quarters of accelerating revenue, margin expansion at the gross line and the operating line simultaneously — not one metric getting cosmetic help while others stay flat, both moving together, which is the signature of real operating leverage, not accounting noise. A forward PE of 20 and a PEG under 1 against a Citi-sized $11 billion TAM by 2030 that nobody on this call disputed even once tonight. A balance sheet that raised capital from strength — equity up, net debt down, current ratio north of 2.4x — not from distress. A named, dollar-quantified customer catalyst on the calendar for late 2026 that the market hasn't priced yet, sitting under a stock trading at a discount to Street targets by more than $100 a share. And a technical picture that, on its own admission, has no directional edge — meaning today's 5.5% drop is exactly as likely to be noise as any rally day was, and treating it as a reason to under-fund a starter position, rather than as the pullback the plan was built to buy, is exactly the kind of asymmetric fear the whole desk agreed not to indulge on the technical side but somehow keeps wanting to indulge on the sizing side.

The stop at $250 already prices the downside. The staged adds already price the confirmation risk. The capex freeze already prices the burn risk. The OCF-and-margin gate already prices the cash-quality risk. There is no leftover risk sitting unpriced that justifies taking the starter tranche below where the fundamentals and the neutral technical read both say it belongs. Forty percent starter, seventy-five percent hard cap, two hundred fifty dollar stop, tranche two on the reclaim with the capex-conditional haircut, final tranche on the two-print confirmation. That's not the aggressive case winning by attrition — it's the plan that actually survived every test thrown at it tonight without needing to invent a new reason every round to keep the number small. Buy it at size the fundamentals and the setup actually earn.

FINAL TRANSACTION PROPOSAL: BUY (starter tranche 40% of standard allocation at ~$279.53; 75% hard cap on total position; stop-loss $250; tranche-two add of +20% gated on daily close above 200 SMA with above-average volume, reduced to +10% if capex at the immediately preceding quarterly print has accelerated versus the trailing-quarter slope — no discretionary/news-based override; final tranche of +15% gated on operating cash flow trend improving across two consecutive prints AND gross margin holding 38%+; freeze on any further adds if quarterly capex exceeds ~$563M with no management guidance toward a declining trajectory)

Conservative Analyst¶

Conservative Analyst: Let me take apart the aggressive case point by point, because what I just heard was a masterclass in cherry-picking the data points that support conviction and waving away everything that doesn't.

Start with the ADX argument, because it's the load-bearing wall of the entire aggressive pitch. The claim is: ADX is 6.34, therefore the MA breakdown is meaningless noise, therefore don't wait for confirmation. But flip that logic around and it cuts exactly the other way. If ADX at 6 means there's no trend in either direction, that's not a green light to buy aggressively — it's a signal that you have zero technical edge right now, bullish or bearish. A trendless, low-ADX, high-ATR regime is precisely the environment where you size DOWN, not up. You don't get to say "the trend indicator is broken, ignore the bearish signal" and then in the same breath say "but trust the fundamental thesis enough to skip confirmation." That's not resolving the contradiction, that's just picking the interpretation that lets you buy more. The honest read of ADX 6.34 is "the market itself doesn't know where this is going," which is an argument for the trader's staged, confirmation-based approach, not against it.

Now the fundamentals. Yes, revenue accelerated four straight quarters, yes margins expanded, yes PEG is 0.92. Nobody's disputing the growth story. What's being waved away is that TTM free cash flow is negative $650 million and getting worse every single quarter — Sep-25 was -$58M, by Jun-26 it's -$493M in a single quarter. That's not a stable capex program, that's an accelerating burn rate with no inflection point in sight yet. The aggressive case wants to frame this as "just like Nvidia's suppliers, everyone looks like this in a buildout." Fine — but Nvidia's suppliers with that FCF profile aren't all equally investable at 20x forward earnings with a 2.10 beta after a 4x run off the lows. This company had to raise $1.85 billion in financing in a single quarter to plug the gap, and operating cash flow itself went negative in the March quarter despite $191 million of net income. When your operating cash flow and your net income are diverging that much, that tells you there's a real quality-of-earnings question buried in those margin numbers — restructuring gains, non-operating items, working capital games. The aggressive analyst breezed past "net income swing to $240.5M, partly aided by non-operating items netting to -$50.4M" like it was a footnote. It's not a footnote. It's exactly the kind of thing that inflates the headline turnaround story you're being asked to pay up for.

On insider selling — I'll grant the point that routine 10b5-1 diversification isn't inherently alarming. But notice what's being conceded here: zero insider buying at current levels. Not one open-market purchase above $104. The CEO bought a token 500 shares near the 52-week low and hasn't touched the stock since it 3x'd. If this is such an obviously mispriced gap versus a $415 average target, where is the insider conviction buying to confirm it? Executives with the best information inside this company are selling into every rally leg from $268 to $325, and the aggressive case wants to explain that away entirely as "that's just what people with equity comp do." Maybe. But it's still a real-world data point that skews toward caution, not toward leaning in harder, and dismissing it outright while simultaneously treating a Rosenblatt $500 price target as gospel is an asymmetric use of "which data to trust."

On the TAM and PhotonLink story — this is a late-2026 revenue ramp that hasn't happened yet. It's a catalyst on a calendar, not in the numbers. Citi's $11 billion TAM by 2030 is a market-wide estimate, not a COHR-specific contracted revenue backlog. Every piece of sentiment data in this report — the news, the world affairs report, StockTwits — independently and repeatedly flags the same theme: COHR is the laggard in this basket. Lumentum up 12% in a month, up 10% versus COHR's 6.9% on the same rally day, Ciena getting an Evercore upgrade on a 58% upside call. The aggressive analyst wants to spin "laggard in a rising basket" as a rotation opportunity waiting to happen. That's a hope, not a signal. Capital rotates when there's a specific catalyst that re-rates the laggard — and the report itself says the PhotonLink ramp isn't expected until late 2026. Between now and then, this stock can keep being the thing capital rotates OUT of into Lumentum and Ciena, and you're the one holding a 2.10 beta name through more of exactly the chop we just watched: 350s to 220s to 350s to 260s to 320s to 280s since June. That is not a stock friendly to aggressive add-ons without confirmation. That's a stock that punishes conviction sizing.

Which brings me to the geopolitical and macro backdrop the aggressive case didn't mention once. Trump-Xi meeting this week, bipartisan Senate bills on Chinese transceivers, IBD explicitly calling out the "can't have both AI buildout speed and supply chain security" trade-off — COHR has real China supply chain exposure sitting under a binary geopolitical event with zero prediction-market hedge available in this data. Layer on top of that: 96% odds of zero Fed cuts in 2026, meaning this high-multiple, high-beta name gets no rate-relief tailwind, and the report explicitly shows COHR rallies and sells off with bond yield moves day to day. You are long a stock that's a levered bet on AI capex durability, rate direction, AND a geopolitical summit outcome, all stacked on top of a company burning half a billion dollars a quarter in free cash flow. That is a lot of stacked, uncorrelated risk to add to on the theory that a coin-flip ADX reading shouldn't be allowed to slow you down.

Now let's talk about what the aggressive analyst wants to actually change in the plan — stripping out the 200 SMA reclaim, volume, and MACD confirmation triggers for the second tranche and replacing them with "PhotonLink customer disclosures" and "capex normalizing commentary." Think about what that really means in practice: you're removing objective, observable, price-based risk controls and replacing them with subjective news-flow interpretation that can be spun bullish by anyone with conviction, at any time, regardless of what the tape is actually doing. That's not a more sophisticated risk framework, that's the removal of a risk framework. The entire point of staged adds with technical confirmation is that it forces discipline in exactly this kind of choppy, high-ATR, no-trend regime where the report itself says signals are noise-prone in both directions. If signals are unreliable, the correct response is to demand more confirmation before committing more capital, not less.

Here's my actual disagreement with the trader's plan, and it's not "don't buy" — the fundamentals are genuinely improving and a small starter position capturing optionality on the AI optics story is defensible. My disagreement is that even 40% starter / 75% cap is too aggressive a ceiling given what's stacked against this name right now: negative and worsening FCF with no visible inflection, zero insider buying at these levels, a documented laggard status versus every peer in its own basket, a binary geopolitical catalyst this exact week, and a stock that just posted an 8%-of-price single-day range on volume that wasn't even confirmed as high. I'd cut the starter tranche to 20-25%, keep the 75% cap as a hard ceiling rather than a floor to build past, and I would not soften the add triggers — if anything I'd add a fourth one: no add-two until the next earnings print shows operating cash flow has turned positive again, not just "narrowing." A company that can't fund its own capex out of operations is a company where the equity is doing double duty as a financing vehicle, and that's a specific, measurable risk this whole aggressive pitch conveniently never quantified once. Protect the capital first. The $11 billion TAM story will still be there in two quarters if the thesis is real — but it won't wait around to bail you out if you're sized at 75% into a name that gaps another 15% on a bad print or a bad Trump-Xi headline. Conservative Analyst: Let me take these one at a time, because both of you landed on a "buy, starter tranche, don't overthink it" consensus that I think glosses over exactly the risk I was hired to flag.

Aggressive analyst — you spent a lot of words this round trying to reframe your own contradiction rather than resolve it. You said ADX 6 means "the technical picture has no edge, bullish or bearish," and then your actual proposal is to let PhotonLink headlines pull the trigger on tranche two early, ahead of the 200 SMA reclaim. That's not neutral treatment of a no-edge environment. That's exactly what the neutral analyst called it: discount the signal you don't like, keep full conviction on the signal you do like, and now you've dressed it up as "two doors into the position" instead of one. Two doors is fine in theory. The problem is one of those doors has no lock on it. "A specific named customer win drops" is not an objective, falsifiable trigger — it's a headline that you and I could read completely differently in real time, with real capital already committed. You're not adding a second confirmation source, you're adding a discretionary override that activates precisely when the stock is going up and the FOMO is loudest. That's the mechanism by which starter positions turn into full positions on vibes.

On OCF — you keep repeating "March was -$93.8M, June was +$69.46M, therefore explained, therefore fine." I'll say it plainly: one positive quarter after one negative quarter is not a trend, it's two data points. You're doing exactly what you accused the conservative case of doing with ADX — treating a noisy, two-print series as if it already tells you the story is resolved. TTM free cash flow is still negative $650 million. Capex is still climbing, not plateauing — $103M to $563M in four quarters is not a number that's shown you a ceiling yet. If capex simply holds flat at Q4's run rate, this company burns more cash next quarter, not less, even if OCF stays marginally positive. You haven't shown me stabilization, you've shown me one good print inside an accelerating capital-intensity cycle. That's not a reason to remove a gate. That's a reason to keep it.

On insider buying — I didn't say the absence of buying is a standalone bear signal, I said it's a data point that should temper how aggressively you lean into "this is an obvious mispricing." You want to have it both ways too: dismiss the selling as routine, then tell me the CEO's $102 buy two years ago is "literally the definition of buying conviction at value" as if that's still informative about today's price. If it was conviction at $102, fine — but conviction at $102 doesn't transfer to a valuation call at $279 with the stock up 3-4x. Nobody with inside knowledge of PhotonLink's actual pipeline, actual customer contract sizes, actual margin trajectory on the ramp has bought a single share above $104. That's not nothing. You don't get to invoke insider buying as bullish evidence from two years ago while waving off its complete absence now.

On geopolitics — you're cherry-picking the bullish half of a two-sided risk. Yes, if the China transceiver bill passes and restricts Chinese suppliers, COHR benefits as an alternative. But IBD's own framing is explicitly "can't have both speed and security" — meaning the more restrictive the policy gets, the more it also risks disrupting COHR's own supply chain, sourcing, and cost structure, given this is a company with real China manufacturing and component exposure post-Coherent/II-VI merger. You've turned a genuinely binary, two-sided catalyst happening this specific week into a one-way tailwind. That's not risk-informed sizing, that's cherry-picking the outcome that supports the trade you already wanted.

On "laggard equals opportunity" — I'd just point out that this framing has now been used to explain away chop, explain away FCF burn, explain away insider silence, and explain away relative underperformance, all with the same underlying logic of "the bad thing is actually secretly good." At some point that's not analysis, that's a thesis that's unfalsifiable. If COHR outperforms, that's the thesis playing out. If COHR underperforms Lumentum and Ciena, that's "the rotation opportunity building." There's no data point in this report that would actually make you say "the market's telling me something." That should worry you more than it seems to.

Neutral analyst — I appreciate that you didn't buy the aggressive case's full reframe, and your OCF-trend-plus-margin-floor compromise is genuinely better than a single-print binary gate, I'll take that improvement. But I think you're underweighting your own point about the macro stacking. You said the geopolitical risks are "generic" and apply to every high-beta tech name — I'd push back on that specifically for COHR, because this isn't a generic semiconductor story, it's a company with a name-checked, bill-specific exposure to Chinese transceiver components this exact week, sitting on top of a balance sheet that already needed a $1.85 billion emergency-style raise seven months ago to fund a capex program still climbing. Generic macro risk hits every stock a little. COHR-specific event risk plus COHR-specific cash-burn trajectory plus COHR-specific 2.10 beta is a stacked risk profile that isn't equivalent to, say, a slower-beta, FCF-positive name catching the same macro headline. The stacking is the point — no single leg is disqualifying, but three elevated-risk legs landing on the same starter position in the same week is exactly when you want a smaller starter, not the same-sized one you'd use in a calmer tape.

I also want to push back gently on your defense of the 40% starter using RSI and z-score as the anchor. RSI 45 and z-score -1.03 tell you the stock isn't at a statistical extreme — fine, I don't dispute that. But that's a statement about mean-reversion positioning, not about fundamental risk. You can have a name that's technically unstretched and still be sitting on a genuinely deteriorating cash conversion story into a binary geopolitical week. Those are two different risk axes and I don't think RSI being neutral should be doing work to justify starter size against a cash-flow and event-risk case it wasn't built to answer.

Here's where I still land, and where I'll adjust from my opening to meet the room halfway on the things you both got right: I'll come off the hard 20-25% starter cut and meet at 30% instead of 40%, specifically to account for the Trump-Xi binary risk landing this exact week — that's a timing issue, not a permanent downgrade, and once the summit passes without a negative outcome, the starter can move toward the standard 40% on the next entry opportunity rather than being chased at today's print. Keep the 75% cap as a hard ceiling, not a floor to build into. Keep the 200 SMA reclaim plus volume trigger fully intact for tranche two — no early trigger on news, full stop, because a discretionary headline override in a confirmed no-edge technical regime is how disciplined position sizing quietly becomes YOLO sizing with extra steps. And I'll take the neutral analyst's OCF-trend-across-two-prints-plus-38%-gross-margin-floor framing for the final tranche over my original single-print gate — that's a real improvement, and I'll own that.

But I want to close on the thing nobody's really sat with tonight: this is a company that had to raise $1.85 billion to keep the lights on for a capex program that is still accelerating, with FCF still $650 million negative on a trailing basis, sizing into a starter position this week specifically because of a stock drop, in the same week as a binary geopolitical catalyst directly relevant to its supply chain, with zero insider conviction buying anywhere near the current price. The fundamentals story is real. I'm not disputing revenue acceleration or margin expansion — those are genuinely good numbers. But "the fundamentals are good" and "this is the right size and the right week to lean into that fact" are two different questions, and only one of them has been answered tonight. Protect the capital first, size for the stacked risk that's actually on the calendar this week, and let the thesis prove itself with an actual FCF inflection before scaling up. The $11 billion TAM isn't going anywhere in the next two quarters. A position sized too aggressively into this specific week's risk stack might not give you the luxury of waiting around for it.

FINAL TRANSACTION PROPOSAL: BUY (reduced starter sizing — 30% of standard allocation rather than 40%, 75% hard cap maintained as ceiling not target, stop at $250 unchanged, tranche-two technical triggers kept fully intact with no discretionary news-based override, final tranche gated on OCF trend improving across two prints plus gross margin holding 38%+) Conservative Analyst: Both of you just built a plan that keeps 40% starter and 75% cap, and I want to be very precise about why I think that's still under-pricing the risk stack sitting on this desk this week — and I want to answer the falsifiability challenge directly, because it's a fair question and I owe you a real answer, not a dodge.

Neutral analyst, you asked what would falsify my 30% cut. Here it is, cleanly: if the summit passes without incident and the stock holds or rallies, I don't get to claim vindication — I underperformed a full-size entry by definition, and the correct response isn't "I was right to be cautious," it's "the size-down cost real return and next time I need a tighter trigger for when event risk actually justifies a haircut versus when it doesn't." That's a real cost, and I'm not pretending it isn't. But notice the asymmetry you're not weighing: the downside scenario isn't just "summit goes badly." IBD's own framing is that the restrictive-policy outcome and the accommodative-policy outcome BOTH carry disruption risk to a company with real China component exposure — "can't have both speed and security" doesn't resolve cleanly bullish either way, and that's before you get to the plain fact that this is a 2.10-beta name sitting through a live macro catalyst with no hedge in this dataset. A smaller starter isn't a bet that the summit goes badly. It's an acknowledgment that I'm being asked to commit capital into a specific 72-hour window of elevated variance on a name that's already proven it can move 8% of its price in a single session on no news at all. That's not "hedging against blame." That's sizing for the actual distribution of outcomes in front of me this week rather than the distribution I'd face on a calmer Tuesday.

Now let's talk about the capex freeze both of you are treating as the night's big consensus win, because I want to push on how weak it actually is as protection. The trigger is: freeze further adds if next-quarter capex exceeds $563M with no glide-path commentary. Think about the sequencing problem here. Capex has 5x'd in four quarters — 104, 154, 290, 563. Under this rule, the position can still add a full second tranche and be sitting at 60% of standard allocation before that checkpoint even fires, because the checkpoint only triggers at the NEXT earnings print, and tranche two is gated on a 200 SMA reclaim that could happen well before then. So the sequence that actually plays out is: stock reclaims the 200 SMA on volume, tranche two goes in, position is now 60% allocated, and only THEN do we find out at earnings whether capex kept climbing. You've built a checkpoint that reacts after more capital is already committed, not before. That's not a freeze that protects the entry, that's a freeze that protects the exit door after the risk has already been taken. If capex risk is real enough to gate anything, it should gate the SIZE of tranche two today, not just future adds after tranche two is already in.

On the OCF symmetry challenge — I'll take it head-on instead of dodging like the aggressive analyst says I did. Yes, I'm applying different weight to a two-year-old $103 buy versus a one-quarter-old OCF swing, and here's why that's not inconsistent, it's about what each data point is evidence of. Insider buying at $103 was informative about conviction at $103 — a price point we are nowhere near, so its relevance today is genuinely low, and I said that plainly. That's not treating it as "stale," that's treating it as calibrated to a price regime that no longer exists. OCF, by contrast, is being invoked by the aggressive case as evidence about a CURRENT and ONGOING question — is the capital-intensity phase stabilizing — and one positive print after one negative print, inside a capex trajectory that's still accelerating in absolute dollar terms, simply hasn't answered that question yet. I'm not applying inconsistent time horizons. I'm asking each data point to be relevant to the specific claim it's being used to support. The CEO's $103 buys support "he had conviction at $103." They do not support "he has conviction at $279." Those are different claims and only one of them is on the table tonight.

To the aggressive analyst — you keep saying I'm "auditioning arguments for a fixed conclusion" because the reasons change round to round while the caution stays constant. Flip that around: the reason the specific risk flagged keeps shifting isn't because I'm fishing for justification, it's because there are genuinely multiple, independent, unresolved risk vectors stacked on this name simultaneously — cash quality, capex trajectory, insider silence, relative-strength laggard status, AND a binary geopolitical event, all in the same data set, all in the same week. You're treating the multiplicity of concerns as evidence of bad-faith reasoning. I'd say the multiplicity of concerns is the actual finding. A stock that only had one of these issues would get a much smaller haircut from me. It's the stacking — not any single leg — that argues for a smaller starter, and neither you nor the neutral analyst has actually rebutted the stacking argument, you've each rebutted one leg at a time as if disposing of any single leg disposes of the case.

And on your accelerant door with the "tightened" definition — a quantified 8-K or press-release PhotonLink disclosure — I'll grant it's more falsifiable than your first version, credit where due. But falsifiable isn't the same as safe to trade on. Think about what actually happens the moment that headline drops: the stock gaps, volume spikes, and you are now trying to add size into a name already moving 8% intraday on no ADX trend to lean on, using a document that tells you nothing about margin profile, ramp timing, or whether the "contracted commitment" is a pilot order or a real production ramp. You'd be adding into exactly the kind of volatility spike this report tells you to size DOWN into, not up into. A falsifiable trigger that still points you toward chasing a gap is a better-worded version of the same mistake, not a fix for it.

Here's my actual position, unchanged in substance, sharpened in mechanism: 30% starter, not 40% — the stacked-risk case stands, nobody's dismantled it, only individual legs have been traded off one at a time. 75% hard cap, no argument there. Tranche two stays technical-only, 200 SMA plus volume, full stop — glad we're all agreed the news-override door stays shut. Final tranche keeps the OCF-trend-plus-margin-floor gate. And I'd amend the capex checkpoint so it isn't just a freeze-after-the-fact: make tranche two's SIZE conditional on capex not having accelerated further at the print immediately preceding the technical trigger — if capex is still climbing steeper than the trailing-quarter slope when the 200 SMA reclaims, cut tranche two from +20% to +10% rather than freezing the tranche after it. That closes the sequencing gap where the freeze fires too late to matter.

This is a real company with a real thesis. I've never disputed that. What I dispute is treating a week with this much simultaneously live, unresolved, negatively-skewed uncertainty as an ordinary week to deploy standard sizing. Protect the capital into the noise, let the PhotonLink ramp and the capex trajectory actually show themselves in the next print, and size up then when the picture is cleaner instead of now while it's stacked against you.

FINAL TRANSACTION PROPOSAL: BUY (reduced starter sizing — 30% of standard allocation at ~$279.53; 75% hard cap maintained as ceiling; stop-loss $250 unchanged; tranche-two add of +20% gated on 200 SMA reclaim with above-average volume, reduced to +10% if capex has accelerated further versus trailing-quarter slope at time of trigger — no discretionary/news-based override; final tranche gated on OCF trend improving across two consecutive prints AND gross margin holding 38%+; capex-plateau freeze on any further adds if next-quarter capex exceeds ~$563M with no management guidance toward a declining trajectory) Conservative Analyst: Let me respond to both of them directly, because I think the last round revealed something important that neither of them wants to sit with.

Neutral analyst, you told me my falsifiability answer proves I'm "paying a toll and calling it prudence" rather than managing risk. I want to push back on that framing specifically, because I think you've quietly adopted a standard that would eliminate ALL discretionary risk management from this plan. Every single risk control in the entire structure we built tonight — the stop, the technical gates, the capex freeze — shares the exact same property you just used to disqualify my starter cut: if the bad outcome doesn't happen, you "underperformed" a version of the plan that skipped the control. That's true of the $250 stop. That's true of the 200 SMA gate. That's true of the capex freeze the aggressive analyst himself just called "functionally a fundamental veto." If a control only counts as "risk-based" when it's also right in hindsight, none of these survive, including the ones you kept. You're holding my sizing decision to a standard you didn't apply to your own mechanisms.

And here's the specific reason a smaller starter and a wider stop are not substitutes, which you asserted but didn't actually demonstrate: a wider stop protects you from noise on a position you already fully own. It does nothing about sequencing risk — the risk that you commit full-intended capital into a name and THEN a binary event breaks badly enough that even a well-placed stop gets you out at a materially worse fill than $250, because this stock gaps. It already gapped 5.5% in a single session on no news at all. A 2.10-beta name with an $11B unlabeled TAM story can gap through a stop on a bad Trump-Xi headline the same way it gapped down today on nothing. Sizing down going into a known binary catalyst reduces the dollar amount exposed to a gap-through scenario that a stop cannot fully control. That's not redundant with the stop, that's addressing a different failure mode than the stop addresses.

Now, aggressive analyst, let me take your TTM FCF symmetry challenge head on, because it's your sharpest shot tonight and it deserves a real answer, not a dodge. You said: if Mar-26's OCF print is decision-relevant, and Jun-26's rebound is "just one print," then TTM FCF blending Sep-25's calm quarter with Jun-26's crisis quarter should be equally discounted. Here's the distinction you're eliding: TTM FCF isn't being cited as a claim about the CURRENT quarterly run-rate — I've been explicit all night that the run-rate is worse than the trailing average, not better, because capex is accelerating within the TTM window, not flat across it. I'm not using -$650M to say "this is what next quarter looks like." I'm using it to say "this is the cumulative cash the company has actually consumed while proving this thesis," which is a claim about balance-sheet burn to date, not about quarterly trend direction. Those are different claims requiring different time horizons, exactly the standard I said I'd apply. The forward-looking claim — is the burn stabilizing — I've already conceded needs recent data, which is why I don't rest on TTM alone for that question, I rest on the fact that capex has shown zero deceleration in absolute dollars for four straight prints. Two different questions, two different appropriate time windows, applied consistently.

On stacking — you said four of my five concerns "got explained, not dismissed" and only average toward the bull case. I'd ask you to notice what "explained" actually means in each case you listed. ADX being explained as "no signal either way" doesn't neutralize risk, it removes a source of conviction FOR the trade just as much as against it — you can't use "ADX is uninformative" to justify holding size and then also count it as a point in the bull column. FCF being "explained by demand-driven capex" doesn't make the cash burn smaller, it makes it forecastable, which is not the same as safe — forecastable burn still requires the forecast to be right, and forecasts about late-2026 ramps have a way of slipping. Insider silence being "low-information given post-run liquidity dynamics" is the neutral analyst's charitable read, not a refutation — the fact remains zero dollars of insider conviction have been committed above $104 in two years of a 4x move. None of these are resolved in the bull's favor. They're recontextualized as less-bad-than-worst-case, which is a very different thing from "average toward the true signal."

Here's my actual bottom line, and I'll make it as simple as the room will let me: this is a company that just told the market, via its own cash flow statement, that it cannot fund its growth plan out of its own operations and needed $1.85 billion to bridge the gap seven months ago — and the gap has not closed, it's widened to nearly $500 million in a single quarter since that raise. It did this while sitting on zero insider buying above $104, a documented laggard position within its own sector, and a live, two-sided, unhedged geopolitical catalyst landing this exact week. Every one of you has found a reasonable-sounding individual reason to wave off each piece of that picture. Nobody has explained why a trader should treat "wave off individually, five times, in one sitting" as equivalent to "no real risk." I'm not asking the desk to skip this name. I'm asking it to buy less of it, into this specific week, and let the position grow once the calendar clears and the capex trajectory actually shows the deceleration everyone here is confidently assuming is coming. Thirty percent starter, unchanged stop, unchanged gates. Protect the capital first — the TAM isn't going anywhere in two weeks, but a full-sized starter position eating a geopolitical gap-through this week is not a mistake you get to undo after the fact.

FINAL TRANSACTION PROPOSAL: BUY (reduced starter sizing — 30% of standard allocation at ~$279.53; 75% hard cap maintained as ceiling, not a target to build toward; stop-loss $250 unchanged; tranche-two add of +20% gated on daily close above 200 SMA with above-average volume, reduced to +10% if capex at the immediately preceding quarterly print has accelerated versus the trailing-quarter slope — no discretionary/news-based override under any framing, tightened or otherwise; final tranche gated on operating cash flow trend improving across two consecutive prints AND gross margin holding 38%+; freeze on any further adds if quarterly capex exceeds ~$563M with no management guidance toward a declining trajectory) Conservative Analyst: Let me respond to both of you directly, because I think you've each just declared victory on points that don't actually settle the question the trader needs answered: is this specific week, at this specific size, the right moment to commit capital to a 2.10-beta name.

Neutral analyst, you said my 30% number "isn't moving because the logic changed, the number is fixed and the logic is being supplied after the fact." I want to push back on that characterization directly, because it inverts what actually happened tonight. Every round, a new piece of the risk picture got raised — ADX, then FCF quality, then insider silence, then capex trajectory, then the summit — and every time, my answer was consistent: none of these individually breaks the thesis, but collectively they describe a name with more simultaneously live uncertainty than a standard entry assumes. The number didn't move because the underlying finding didn't move. You're treating consistency as evidence of motivated reasoning when it's actually just... consistency. If I'd started at 30% because of FCF and ended at 30% because of the summit, that would be suspicious. I started at 30% because of stacked risk and I'm ending at 30% because the stack never got dismantled — you and the aggressive analyst took turns explaining individual legs away, but nobody addressed the compounding.

And on the gap-risk point — you're right that I should be more precise about mechanism, so let me be precise. You say the fix for gap risk is "execution awareness and order-type management," not sizing. But think about what that actually means operationally: on a stock with a documented history of 8%-of-price single-session moves on no news at all, "order-type awareness" around a live binary geopolitical event means what, exactly? A stop-limit instead of stop-market, so you don't get a bad fill but risk not getting filled at all in a fast market? Options collars, which the desk may not even have approved for this name? These are fine ideas in principle, but they're not concrete enough to replace a sizing decision tonight. Dollar exposure reduction is the one lever every desk can execute cleanly, immediately, without new infrastructure. "Manage it through execution" is the theoretically elegant answer and "reduce the amount of capital exposed to the event" is the answer that actually works Monday morning.

Aggressive analyst, I want to take your double-billing argument seriously because it's your best structural point tonight, but I think it collapses under its own weight. You say every risk already has a gate — capex freeze catches capex, OCF gate catches cash quality, stop catches price — so tranche one shouldn't carry any discount. But look at what those gates actually protect against: they protect the position going forward, from this point on. None of them retroactively protect the capital that's already been deployed at the moment those risks are live. The capex freeze doesn't help you if capex was already accelerating the day you bought the starter tranche — it only stops you from adding MORE on top of a starter that's already exposed. The OCF gate doesn't protect tranche one from a bad print, it just stops tranche three from getting added on top of a bad one. You're describing a plan that protects the marginal dollar extremely well and does nothing for the first dollar. That first dollar is exactly the one going in this week, into a summit, into a stock that already proved today it can move 8% on literally nothing. The gates are good. They're just answering a different question than "how much should the first tranche be, given that this particular week carries identifiable, undiversifiable event risk that the rest of the calendar doesn't."

On TTM FCF — you're pressing me to "pick one job" for that number, backward-looking or forward-alarming, as if those are mutually exclusive. They're not. A cumulative burn figure can be simultaneously descriptive of the past AND relevant to forward risk capacity, because burned cash is cash that no longer exists to cushion the NEXT bad quarter. That's not smuggling forward-looking alarm into a backward number — that's just what a balance sheet is. The $1.85B raise happened in March. By June, FCF for that single quarter alone was worse than the entire capital raise divided by four. If that pace continues, the cushion the raise bought gets tested again inside two quarters — that's not a re-interpretation of TTM FCF, that's simple arithmetic about run-rate versus reserves, and neither of you has actually rebutted the math, you've rebutted the tone.

And on stacking — you both keep saying the individual legs "got explained." Explained is not the same as neutralized. ADX being uninformative doesn't help the bull case, it just removes technical conviction from both sides, which is exactly why leaning on fundamentals alone to justify a full-size entry into that vacuum is riskier, not safer. Insider silence being "post-run liquidity dynamics" is a plausible excuse, not evidence of confidence. Geopolitics being "two-sided" doesn't erase the downside tail, it just means you can't fully hedge it either way, which is itself an argument for temporary caution, not full commitment. None of these got resolved bullish. They got contextualized as survivable. Survivable individually, stacked simultaneously, in the same seven-day window, on a name that already gapped 5.5% on a day with zero identifiable catalyst — that's not me inventing fear, that's me refusing to pretend a quiet week and this week carry the same risk profile.

My position doesn't change: 30% starter, same $250 stop, same technical gates, same OCF-and-margin final tranche, same capex freeze. Let the summit pass, let the next print show whether capex actually decelerates the way everyone here is confidently assuming it will, and size the position up from there with real information instead of hope. The TAM will still be enormous in three weeks. The stacked risk sitting on the desk this exact week will not still be sitting there in three weeks — and that asymmetry, not the one the aggressive analyst keeps citing about upside, is the one that should actually govern tonight's size.

FINAL TRANSACTION PROPOSAL: BUY (reduced starter sizing — 30% of standard allocation at ~$279.53; 75% hard cap maintained as ceiling, not a target; stop-loss $250 unchanged; tranche-two add of +20% gated on daily close above 200 SMA with above-average volume, reduced to +10% if capex at the immediately preceding quarterly print has accelerated versus the trailing-quarter slope — no discretionary/news-based override under any framing; final tranche gated on operating cash flow trend improving across two consecutive prints AND gross margin holding 38%+; freeze on any further adds if quarterly capex exceeds ~$563M with no management guidance toward a declining trajectory)

Neutral Analyst¶

Neutral Analyst: Alright, let me referee this, because both sides just spent a lot of energy building internally consistent cases that each ignore half the evidence board.

Let's start with the aggressive analyst, because the ADX argument is doing way more work than it can bear. You said ADX 6.34 means "ignore the MA breakdown, it's noise" — and then in the very next breath you used that same low-ADX environment to argue for stripping out MA/volume/MACD confirmation triggers on the add tranches. That's not resolving the tension, the conservative analyst nailed this — you can't selectively suspend an indicator only when it disagrees with you and then argue for removing the very discipline that indicator's unreliability should be reinforcing. If ADX 6 means "the market doesn't know where this is going," the correct inference isn't "so trust my fundamental read with more size" — it's "so don't let anyone's directional conviction, bullish or bearish, get oversized right now." You want it both ways: discount the bearish technical, keep the bullish fundamental at full conviction. That's not neutrality, that's motivated reasoning with extra steps.

I'd also push back on how you handled free cash flow. "Everyone in an AI buildout looks like this" is true in general but it's not actually true here in the specific way that matters — operating cash flow went negative in the March quarter while net income was positive $191 million. That's not "the company is investing aggressively," that's a gap between reported earnings and cash generation that deserves scrutiny on its own, independent of the capex story. You folded that into the broader "funded growth phase" narrative without addressing it directly. That's a real gap in the aggressive case, not just conservative nitpicking.

Now the conservative side — there's a lot of good discipline in there, but a few things are overstated. The "zero insider buying" point gets used as if it's a standalone red flag, but you already conceded yourself that insider selling is largely routine 10b5-1 diversification. You can't fully discount the selling as noise and then treat the absence of buying as meaningful signal — executives rarely buy in the open market once a stock has already run this far regardless of how convicted they are; that's a liquidity and optics decision as much as a fundamental one. It's a fair soft data point, but you're leaning on it harder than its actual information content supports.

The geopolitical stacking is also doing some rhetorical heavy lifting. Trump-Xi, Fed odds, China transceiver bills — these are real, but they're generic macro risks that apply to basically every high-beta tech name right now, not COHR-specific reasons to cut the starter tranche in half. If you want to make that argument seriously, it needs to translate into a specific position-sizing number tied to event risk around a specific date, not just "there's a lot of stuff going on."

And the "operating cash flow must turn positive before add-two" trigger — I actually like the instinct, but as an absolute gate it's too rigid. June quarter OCF was already back to positive $69 million after the March dip. If you require a full confirmed positive OCF print before adding at all, you may end up waiting through an entire re-rating on a technicality, especially since capex lumpiness alone can flip OCF between quarters even as the underlying trend genuinely improves. Cut the tranche size, fine — but make it a trend-based check across two prints, not a single binary gate.

Here's where I land. The bull case for the business is real — four quarters of sequential revenue acceleration, margin expansion that's actually showing up in operating leverage, not just gross margin, and a PEG under 1 is a legitimate valuation argument, not a fantasy. But the bear case on cash quality is also real and unresolved — negative, worsening FCF, an OCF/net income divergence that hasn't been explained away, and a name that just had an 8%-of-price range day in a regime with literally no measurable trend, up or down. Both of those things are true at the same time. That's exactly why the trader's original starter-tranche-with-staged-adds structure is closer to correct than either debate side wants to admit.

Where I'd actually adjust it: keep the 40% starter, I wouldn't cut it to 20-25% — the conservative case for that cut leans too much on generic macro overlay rather than COHR-specific deterioration, and RSI at 45 with z-scores unstretched genuinely doesn't support treating this as a broken stock. But I also wouldn't strip out the technical confirmation triggers the way the aggressive analyst wants — replacing objective triggers with subjective news interpretation in a no-trend tape is how you talk yourself into averaging up on vibes. Keep the 200 SMA reclaim plus volume trigger for tranche two exactly as the trader has it — that's your objective check against buying into continued chop. But soften the final tranche trigger from a single-quarter "OCF must be positive" hard gate to "OCF trend improving across the next print plus gross margin holding 38%+" — that captures the conservative analyst's legitimate cash-quality concern without making it an all-or-nothing bet on one lumpy number.

On the cap: 75% total is the right ceiling given the beta and the ATR — I wouldn't raise it to accommodate the aggressive case's "lean in harder" instinct, and I wouldn't lower it to accommodate the conservative case's macro stacking, because the stop at $250 already does real work here — it sits below the recent range low and gives the position room to breathe through exactly the kind of chop both the technical and social data describe.

Net: this is a buy, starter-sized, staged, with technical gates intact but the final gate made trend-based instead of single-print binary. Both of you are right about a real risk and wrong about how much it should move the sizing dial — the aggressive case underweights cash-quality risk to justify leaning in, the conservative case overweights generic macro noise to justify pulling back. The plan as originally structured already threads that needle better than either revision proposed tonight. Neutral Analyst: Alright, both of you just did another lap around the same track, and I want to call out where each of you is still overreaching before I land this.

Aggressive analyst — I gave you credit last round for landing closer to my compromise on the OCF trigger, but this round you tried to cash that concession in for something bigger than you earned. The "two doors, one floor, one accelerant" framing sounds sophisticated, but the conservative analyst is right that a discretionary news trigger with no falsifiability criteria is not a second confirmation source, it's a bypass valve. Think about how this actually plays out in real time: a headline drops — "Coherent announces PhotonLink customer win" — with zero detail on contract size, timing, or margin profile, and under your rule that's enough to add tranche two before the 200 SMA reclaims. Who adjudicates whether that headline is "real, forward information the market hasn't priced" versus PR-department confirmation of something already assumed? You would, in the moment, with money already committed and a stock presumably ripping on the news. That's not a trigger, that's you giving yourself permission to override the technical gate whenever you're excited. I'm not adopting it. The 200 SMA plus volume trigger stays as the only gate for tranche two, full stop — not because I think MACD and MA crossovers are gospel in a low-ADX tape, but because the alternative you're proposing has no discipline at all, and you've now tried to smuggle it in twice under different names.

But conservative analyst, I'm not letting you off easy either, because your closing point — "there's no data point that would make the aggressive case say the market's telling you something" — is a sharp rhetorical hit, but it applies to your own position too. You cut the starter to 30% this round specifically because of "this exact week's" Trump-Xi binary risk, and you're explicit that this is a timing call, not a thesis downgrade — the starter goes back to 40% "on the next entry opportunity" once the summit passes cleanly. I'd ask you the same question you just asked the aggressive analyst: what actually falsifies this? If the summit passes with no bad headline, you were right to size down for a risk that didn't materialize, and you take the win on the next entry. If the summit produces a bad headline, you were right to size down, full stop. There's no outcome in which "cut size ahead of a binary event" gets marked wrong in your own framework, which means it's not really risk-based sizing, it's just a hedge against ever being blamed for a headline. That's a real tell. A genuinely risk-adjusted position size should be defensible on the fundamentals and technicals in front of us today, not on a discretionary haircut for an event that IBD itself frames as two-sided — and you conceded it's two-sided in the very same paragraph you use it to justify cutting size only on the downside.

Here's the other place you're overcorrecting: you're treating one negative OCF quarter as proof of an accelerating structural burn, while treating the CEO's two $103 buys as fully stale evidence with zero ongoing informational value. You can't have it both ways on time horizons. If Mar-26's -$93.8M OCF print is decision-relevant today, then so is the fact that Jun-26 already bounced to +$69M — you don't get to cite the scary data point as current and wave off the encouraging one as "just two prints, not a trend" while also treating two-year-old insider buying as permanently informative in the other direction when it suits the caution case. Pick a consistency rule and apply it symmetrically.

Now let me hit the thing both of you are actually dancing around instead of resolving: capex trajectory. Neither of you has actually engaged with what happens if capex simply plateaus versus keeps climbing. Aggressive analyst, you keep saying "this is a funded growth phase" like the $1.85B raise settles the question — it doesn't, because that raise happened in March and by June FCF burn had still worsened to -$493M for the quarter. If capex growth continues at anything like the trailing four-quarter slope, that cushion gets tested again inside of two more quarters, raise or no raise. That's not a survival crisis, I agree with you there, but it is a real reason the position should not be sized as if the fundamental picture is fully de-risked. Conservative analyst, you're right to flag this, but your response — cut the starter by 10 points because of a geopolitical calendar event that's unrelated to the capex question — doesn't actually address the capex risk at all. You're solving the wrong problem with your sizing cut.

So here's where I land, and I'm not splitting the difference for the sake of splitting it — I think the original plan structure was closer to right than either revision, and neither of tonight's pushes changes that. Starter stays at 40%, not 30%. The RSI-neutral, z-score-unstretched, ADX-no-edge picture doesn't support treating this print as a moment requiring a below-standard starter size — that would be using a technical, no-signal environment to justify a fundamentally-motivated conclusion it wasn't built to support, which is exactly the conservative analyst's own complaint about RSI when I made a similar point last round, so I'll hold myself to it. The 75% cap stays as a hard ceiling, not a target — nobody's proposed moving it, good, it stays. Tranche two stays gated on the 200 SMA reclaim plus above-average volume, no discretionary news override, no accelerant door — that mechanism gets rejected again for the same reason it got rejected last round: it has no falsifiability and it's already been used twice tonight to try to re-introduce conviction sizing through the back door. Final tranche keeps the OCF-trend-across-two-prints-plus-38%-gross-margin-floor gate — both sides already agreed this is better than either original version, so that part's settled.

The one adjustment I will make, and this is new: given that both of you actually raised legitimate, distinct points tonight — the aggressive analyst's fair hit that a three-way technical stack from the same low-ADX indicator family shouldn't be treated as bulletproof confirmation, and the conservative analyst's fair hit that capex hasn't shown a ceiling yet — I'd tighten the stop discipline rather than touch the entry size. Keep the stop at $250, but add an explicit capex checkpoint at the next earnings print independent of the OCF/margin gate: if quarterly capex prints above $563M with no management commentary on a glide path down, that's grounds to freeze all further adds regardless of what the technical or OCF gates say, even if they'd otherwise trigger. That directly answers the capex-trajectory risk neither of you actually resolved tonight, without borrowing the conservative analyst's event-driven haircut or the aggressive analyst's news-override mechanism.

Buy it, 40% starter, 75% hard cap, stop at $250, tranche two on 200 SMA reclaim plus volume only, final tranche on OCF trend plus margin floor, with a new explicit capex-plateau checkpoint gating any further adds. That's the version that actually prices in both of tonight's real objections instead of one side's calendar anxiety or the other side's headline-trading impulse.

FINAL TRANSACTION PROPOSAL: BUY (starter tranche 40% of standard allocation at ~$279.53; 75% hard cap on total position; stop-loss $250; tranche-two add of +20% gated on daily close above 200 SMA with above-average volume — no discretionary/news-based override; final tranche of +15% gated on operating cash flow trend improving across two consecutive prints AND gross margin holding 38%+; additionally, freeze all further adds if next-quarter capex exceeds ~$563M with no management guidance toward a declining capex trajectory, regardless of whether technical or cash-flow gates are otherwise satisfied) Neutral Analyst: Alright, let's close this out, because I think both of you actually made real progress tonight before drifting back to your priors in these last two exchanges, and I want to name exactly where each of you overshot.

Aggressive analyst — the "you already accepted my premise with the capex freeze" move is clever but it doesn't hold up under its own logic. There's a structural difference between a veto and an entry trigger that you're eliding. A freeze on further buying when a risk materializes is a defensive, asymmetric-cost action — if I'm wrong to freeze, the cost is deferred upside, fully recoverable the next time a technical or fundamental gate fires. An accelerant that pulls forward a buy is an offensive, harder-to-reverse action — if I'm wrong to trigger early, the cost is capital committed into a headline-driven spike with a stop that's now closer in percentage terms because I bought higher. Those aren't symmetric decisions just because they both reference fundamental data, and treating them as mirror images of the same mechanism is exactly the kind of clever reframe that sounds principled but isn't. I'll also point out you narrowed your own definition twice tonight — first "any PhotonLink headline," then "a quantified 8-K disclosure" — and even your tightened version still fires into a name that just proved it can move 8% intraday on literally nothing. A falsifiable trigger that still routes you into chasing a volatility spike isn't a fix, it's a better-dressed version of the same problem, and the conservative analyst is right about that specific point even if I don't agree with her overall sizing.

Conservative analyst — I asked you directly what falsifies the 30% cut and you gave me an honest answer this time, credit for that. But look at what you actually said: "if the summit passes cleanly, I underperform, and I learn to use a tighter trigger next time." That's a p&l cost you're accepting, not a risk model producing a number. A real risk-based sizing framework would tell you the summit is a two-sided, unhedged binary and therefore argue for a wider stop or a shorter holding period ahead of it — not a smaller starter combined with an unchanged $250 stop and an unchanged intent to size back to 40% the moment the calendar clears. You're not actually managing the geopolitical risk, you're paying a toll for it and calling the toll "prudence." And your sequencing critique on the capex freeze is your best point tonight — you're right that a freeze-only mechanism lets tranche two go in before the next print confirms anything. But your fix — cutting tranche two from 20 to 10 if capex accelerated at the print immediately preceding the SMA reclaim — is actually a good, falsifiable, timing-correct mechanism. I'm taking that one. It closes a real gap without requiring the 30% starter cut to go with it.

Here's the thing both of you keep skating past: the technical report and the fundamentals report are not actually in conflict, they're describing two different clocks. ADX at 6 tells you the market has no near-term directional opinion on COHR. The fundamentals tell you the multi-quarter trajectory — margins, revenue, TAM — is real. Those can both be true, and the correct response to "no technical edge, real fundamental trajectory" was never "go big" or "go small," it was always "enter what the fundamentals justify as a floor, size the rest off confirmation, and make sure your risk controls actually fire in the order the risk actually shows up." That's the 40% starter. Not because RSI or z-score tells you to be aggressive — it doesn't, and I said that last round — but because nothing in tonight's four rounds produced a COHR-specific reason, as opposed to a generic macro-calendar reason, to under-fund a starter position in a name with four straight quarters of accelerating revenue and expanding margin at every level above the one-time-items line.

So here's the actual plan, and it's not a split-the-difference cop-out, it's built from the two things that survived scrutiny tonight and rejects the two things that didn't:

Starter stays 40%, not 30%. The conservative cut doesn't survive its own falsifiability test — it's a calendar toll, not a risk-calibrated number, and it would apply the same logic to every single-name position ahead of every macro print forever if you let it. 75% hard cap stays, nobody contested it, it stands. Stop stays $250, it already does the real protective work here given the ATR.

Tranche two: gated on 200 SMA reclaim plus above-average volume, exactly as designed. No news-based accelerant door — aggressive analyst, I heard the tightened version, and it's better, but "adjudicable in a document" isn't the same as "safe to size into," and the conservative analyst is correct that you'd be adding into the exact volatility spike this report tells you to size down into, not up into. The door stays shut. But I am taking the conservative analyst's sequencing fix: if capex at the print immediately preceding the SMA reclaim has accelerated further versus the trailing-quarter slope, tranche two is cut from +20% to +10%, not frozen. That's a real, timing-correct improvement neither original plan had, and it directly answers the "freeze fires too late" critique without smuggling in a starter-size cut to compensate for a problem it doesn't actually solve.

Final tranche: unchanged from where all three of us converged — OCF trend improving across two consecutive prints, not a single-print binary, plus gross margin holding 38%+. That's settled and it's good.

Capex checkpoint: keep the freeze on any further adds if capex exceeds $563M with no glide-path commentary, now working in tandem with the tranche-two haircut instead of instead of it — so the risk is priced twice, once at the point of the add and once as an ongoing freeze condition, which closes the sequencing gap completely.

That's the version that actually reflects what happened tonight: the aggressive case is right that fundamentals deserve real standing and that stacking three signals from one broken indicator family isn't rigor, but wrong that a fundamental headline should be allowed to override a no-edge technical tape on the entry side. The conservative case is right that the capex-freeze mechanism had a sequencing hole and deserved a sharper fix, but wrong that a two-sided, unhedgeable macro calendar event justifies a smaller starter on a name where every company-specific number kept improving through four straight quarters. Buy it — 40% starter, 75% cap, $250 stop, tranche two on technical reclaim with a capex-conditional haircut instead of a same-size add, final tranche on the two-print OCF-and-margin gate, freeze intact as backstop. That's the structure that prices every real risk raised tonight without paying for the ones that were just dressed-up hesitation or dressed-up conviction.

FINAL TRANSACTION PROPOSAL: BUY (starter tranche 40% of standard allocation at ~$279.53; 75% hard cap on total position; stop-loss $250; tranche-two add of +20% gated on daily close above 200 SMA with above-average volume, reduced to +10% if capex at the immediately preceding quarterly print has accelerated versus the trailing-quarter slope — no discretionary/news-based override; final tranche of +15% gated on operating cash flow trend improving across two consecutive prints AND gross margin holding 38%+; freeze on any further adds if quarterly capex exceeds ~$563M with no management guidance toward a declining trajectory, regardless of whether technical or cash-flow gates are otherwise satisfied) Neutral Analyst: Alright, final word, and I'll be direct about who's still overreaching after four rounds of otherwise useful sharpening.

Aggressive analyst, your closing has one real logical hole you're skating past: you say "nobody produced a COHR-specific reason to under-fund the starter," and then in the very next breath you list ADX, FCF, insider silence, geopolitics, and laggard status as the five things that got raised — every one of which is, definitionally, COHR-specific data. You're not disputing that these are real, company-level facts. You're disputing the weight assigned to them. That's a legitimate argument to make, but it's not the argument you're making — you're making a "nothing here is real" argument when your actual position is "these are real but I think they're outweighed." Say that instead, because it's more defensible than pretending five rounds of substantive pushback amount to nothing.

And on your TTM FCF symmetry point against the conservative analyst — it's clever, but it actually proves her distinction, not yours. She's using TTM FCF as a cumulative burn-to-date figure, which is legitimately backward-looking by design; nobody disputes what TTM means. You're trying to catch her in an inconsistency by comparing that to a forward-looking claim about OCF stabilizing, but those genuinely are different questions with different appropriate windows. That's not a gotcha, that's her being precise. Where I think she is overreaching is elsewhere — not there.

Conservative analyst, here's where you're still overshooting. Your gap-through argument against my stop-versus-starter-size point is actually a reasonable technical addition — I'll take it, that's a real distinction between noise protection and sequencing/gap protection that I underweighted last round. Credit given. But notice what you did with it: you used a legitimate point about gap risk to justify the same 30% number you've been defending all night for a rotating cast of other reasons. If gap-through risk is the real issue, the answer isn't "cut the starter by 10 points," it's "widen the stop or use a mental/hard stop structure that accounts for typical gap size on this name" — which is a stop-design fix, not a position-size fix. You keep converging on 30% no matter which argument wins the round. That's the aggressive analyst's strongest read of you tonight and it's correct: the number isn't moving because the logic changed, the number is fixed and the logic is being supplied after the fact.

And your insider-buying-versus-TTM-FCF consistency defense doesn't fully hold either. You say the CEO's $103 buy is "calibrated to a price regime that no longer exists" but TTM FCF gets full current weight because it's "cumulative burn to date." Fine — but cumulative burn to date includes Sep-25's -$58M quarter, which was generated in a materially calmer capex regime than today's. If you're going to discount the insider buy because the price regime shifted, you should at minimum flag that a third of your TTM FCF number was generated before capex started its 5x ramp. You didn't do that — you presented -$650M as a flat, undifferentiated scary number while asking us to time-weight everything else.

Here's the actual synthesis, and it's not a cop-out to land back near where the trader started, because both of you spent four rounds trying to move off that anchor and neither of you produced the evidence to justify moving it.

On the aggressive side: the accelerant door is dead, correctly, for the third time — not because fundamental information can't be real, but because you've now proven, by narrowing your own definition twice under pressure, that the version safe enough to defend is also the version too narrow to matter and the version broad enough to matter is also the version that routes capital into a volatility spike with no price-based confirmation. That's not a compromise waiting to be found, that's the mechanism being structurally unfixable at the entry point. Leave it dead.

On the conservative side: 30% doesn't survive because every fresh justification for it this round — the toll-payment admission on the summit, the gap-through argument — describes reasons to manage risk through the stop, through gap-aware execution, or through the tranche-two capex haircut we already built, not reasons to shrink tranche one. You've essentially been asking the position size to do a job that belongs to the stop and the staged-add gates. That's over-engineering caution into the wrong lever.

So: 40% starter stands. Not because the fundamentals guarantee anything — they don't, and the conservative analyst is right that stacked, unresolved risk exists — but because RSI neutral, z-scores unstretched, and ADX showing no directional edge in either direction means this specific print, this specific week, doesn't statistically justify a below-standard entry any more than it justifies an above-standard one. 75% hard cap, unmoved all night for good reason. Stop at $250 stays, but I'll adopt the conservative analyst's gap-risk framing as a live monitoring item rather than a sizing change — if COHR gaps through $250 on a bad geopolitical headline, that's a fill-quality problem the desk manages through order type and timing around the summit, not something a smaller starter retroactively fixes, since a smaller position gapping through its stop just loses a smaller amount at a still-worse-than-intended price. Tranche two stays exactly as we built it — 200 SMA reclaim plus volume, cut to +10% if capex has accelerated further at the preceding print, no news override. Final tranche stays on the two-print OCF trend plus 38% margin floor. Capex freeze stays as backstop.

That's the plan. It's not a victory lap for either side — the aggressive case loses its accelerant door permanently, and the conservative case loses its starter-size cut permanently, and what's left standing is the structure that survived actual cross-examination four rounds running rather than the structure either side simply kept re-asserting.

FINAL TRANSACTION PROPOSAL: BUY (starter tranche 40% of standard allocation at ~$279.53; 75% hard cap on total position; stop-loss $250, with gap-risk around the Trump-Xi summit managed via execution/order-type awareness rather than reduced entry size; tranche-two add of +20% gated on daily close above 200 SMA with above-average volume, reduced to +10% if capex at the immediately preceding quarterly print has accelerated versus the trailing-quarter slope — no discretionary/news-based override, permanently rejected as a mechanism; final tranche of +15% gated on operating cash flow trend improving across two consecutive prints AND gross margin holding 38%+; freeze on any further adds if quarterly capex exceeds ~$563M with no management guidance toward a declining trajectory, regardless of whether technical or cash-flow gates are otherwise satisfied) Neutral Analyst: Alright, six rounds in, and I want to close this out by naming exactly what each side is still getting wrong, because both of you spent the last exchange scoring rhetorical points that don't actually move the number that matters.

Aggressive analyst, your "double-billing" argument is the cleverest thing said tonight, but the conservative analyst's rebuttal to it lands and you didn't really answer it — you moved past it. She's right that every gate you cite protects the marginal dollar, not the first dollar. The capex freeze can't un-buy a starter tranche that goes in the same week capex is still climbing. The OCF gate can't retroactively protect capital deployed before the next print exists. That's not a small technicality, it's the actual structure of the plan: tranche one is the only piece of capital in this entire architecture that goes in with zero confirmation of anything — no technical trend, no OCF trend, no capex plateau, nothing. You keep saying "the fundamentals earn the size," but the fundamentals report itself is the one flagging TTM FCF of -$650M, an OCF/net-income divergence in the same quarter net income printed $191M, and zero insider buying above $104. Those aren't conservative inventions, they're in the data you're asking the trader to lean into at full standard size. You don't get to call a full 40% starter "earned" by a picture that even you concede has real, live, unresolved question marks — you get to call it earned once those question marks resolve, which is literally what the staged structure already assumes will happen later, not now.

But conservative analyst, here's where you're still overreaching too, and it's the same flaw across six rounds: you keep re-deriving the same 30% number from a rotating cast of justifications, and when the neutral analyst or the aggressive analyst dismantles the current one, you produce a new one that lands on exactly 30% again. That's not stacking evidence, that's motivated reasoning with a fixed target. Your gap-risk argument tonight is genuinely your best point of the whole debate — a stop doesn't protect against a gap, that's correct and it's a real distinct failure mode nobody else raised cleanly. But then you used a precise, mechanism-specific insight to justify an imprecise, linear haircut that has nothing to do with the actual variance of a two-sided geopolitical binary. If gap risk through the summit is the real concern, the correct response is time-bound, not permanent — something like "hold the starter at 40% but don't authorize any add until the summit outcome is known," not "cut the starter itself by 25% indefinitely and call it done." You're using a surgical insight to justify a blunt instrument, and that mismatch is exactly what the aggressive analyst keeps catching you on.

Here's what I think actually survived four rounds, cleanly, from each side, and here's the plan that reflects it instead of either camp's attrition-by-repetition.

From the aggressive side: real point — three MA/MACD signals from the same broken low-ADX indicator family shouldn't be treated as bulletproof confirmation, and the fundamental trajectory (four straight quarters of both gross and operating margin expansion, moving together, not one metric covering for another) is genuinely strong evidence of real operating leverage, not noise. That's earned a standard starter, not a discounted one.

From the conservative side: real point — the first tranche is genuinely the only uncushioned capital in this plan, and it's going in during a week with a specific, live, two-sided, unhedged event risk that the rest of the calendar doesn't carry. That's not stacking five weak arguments, that's one legitimate, time-bound argument: event risk this week is real and asymmetric to a stop that only manages price, not gaps.

So here's the adjustment I'm actually making, and it's not a cop-out split — it's mechanism-matched to the specific risk identified. Keep the starter at 40%, not 30% — the conservative case never produced a COHR-specific reason to permanently under-fund tranche one, and a static haircut untethered to any triggering event is a worse tool than what I'm about to propose. But address the gap-risk point for real, on its own terms, the way it was actually raised: split execution of the 40% starter into two clips instead of one lump entry — roughly 25% now at $279.53, and hold the remaining 15% of the starter until after the Trump-Xi summit concludes, filling it either at market or better if the stock is flat-to-up post-summit, and only skipping it if the stock has already gapped hard through the stop zone on a bad outcome, in which case you reassess rather than chase. That's a real answer to gap risk — it reduces the dollar amount exposed to the specific 72-hour window in question — without permanently shrinking the position size the fundamentals actually support, and without pretending a static 30% number is a risk control when it's really a guess with no trigger and no expiration built into its own definition.

Everything else stays exactly where four rounds of cross-examination left it, because it survived: 75% hard cap as ceiling, not target. Stop at $250. Tranche two on 200 SMA reclaim plus above-average volume, cut to +10% if capex has accelerated further at the preceding print — no discretionary or news-based override, that door is closed for good, both of you effectively agreed the falsifiable version is still too narrow to matter and the useful version still routes capital into a spike. Final tranche on OCF trend across two consecutive prints plus gross margin holding 38%+. Capex freeze on any further adds if quarterly capex exceeds ~$563M with no glide-path commentary, working alongside the tranche-two haircut rather than instead of it.

That's the version that actually prices the one specific, surviving objection from each side instead of rewarding whichever analyst repeated their number the most times. Full-size conviction where the data supports it, a real but time-bound accommodation for the one legitimate event-risk gap nobody else's mechanism actually covered.

FINAL TRANSACTION PROPOSAL: BUY (starter tranche 40% of standard allocation, executed in two clips — 25% immediately at ~$279.53 and the remaining 15% following resolution of the Trump-Xi summit, contingent on no disqualifying gap-down through the stop zone; 75% hard cap on total position as ceiling not target; stop-loss $250; tranche-two add of +20% gated on daily close above 200 SMA with above-average volume, reduced to +10% if capex at the immediately preceding quarterly print has accelerated versus trailing-quarter slope — no discretionary/news-based override; final tranche of +15% gated on operating cash flow trend improving across two consecutive prints AND gross margin holding 38%+; freeze on any further adds if quarterly capex exceeds ~$563M with no management guidance toward a declining trajectory)

V. Portfolio Manager Decision¶

Portfolio Manager¶

Rating: Overweight

Executive Summary: Build COHR gradually, not all at once. Target total exposure is 75% of a standard allocation, used as a ceiling. Start with 40%, bought in two parts: about 25% now near $279.53 and the other 15% after the Trump-Xi summit, unless the stock has gapped down toward the stop. Add +20% on a daily close above the 200-day SMA (~$286.59) with above-average volume. Cut that add to +10% if capex sped up again in the latest quarter. Add the last +15% only if operating cash flow improves over two straight reports and gross margin stays at 38% or higher. Stop out on a daily close below $250. Freeze all adds if quarterly capex tops ~$563M without guidance that it will come down. If you already own COHR, move toward these levels rather than stacking them on top of your position.

Investment Thesis: The business results favor the bull, and none of the analysts disputed them. Revenue grew from $1.58B to $2.05B over four quarters that each grew faster than the last. Gross margin rose every quarter, from 36.6% to 38.5%. Operating margin went from 10.9% to 14.9%. Net income swung from -$95.6M to +$240.5M. The stock trades at 20x forward earnings with a PEG of 0.92, which is not an expensive price for that growth. Gross and operating margins widening together while capex rose about 5x points to real demand and pricing power. The bear side never answered that directly.

The bear's case on cash is the real counterweight. Free cash flow went -$58M, -$96M, -$383M, -$493M (trailing twelve months: -$650M). Inventory grew 58% while revenue grew 29%. Operating cash flow was negative in March even though net income was $191M. The $1.85B raise diluted shareholders, and the burn got worse after it. At roughly $490M a quarter against $1.16B of cash, another raise or more borrowing within 2–3 quarters is plausible. Still, this is a question of dilution and timing, not survival. Net debt is about $2.06B against a ~$55B market cap, and the current ratio is 2.43x.

The chart doesn't give an edge either way. The stock broke below its 10-day, 50-day and 200-day averages, but ADX is about 6, RSI is 45 and z-scores are not stretched. That tells us how to time entries, not which way to lean. All three risk analysts ended at a staged Buy. They disagreed only on how big the starter should be and how to trigger adds, and those arguments settle the details.

1) Starter size: 40%, not 30%. The Conservative analyst's 30% cut was never tied to a trigger or an end date. Her one strong point was that a stop can't protect against an overnight gap during a binary event. The Neutral analyst answered that with the right tool, a time-limited split: 25% now and 15% after the summit. 2) No news-based early add. The Aggressive analyst wanted a PhotonLink customer announcement to trigger an early add. That was rightly rejected. Any version narrow enough to judge objectively was too narrow to matter, and the broader version would mean buying into a volatility spike. 3) Capex sequencing. The Conservative analyst showed that a freeze that only kicks in at earnings comes too late. The fix is to shrink add #1 if capex sped up in the latest quarter, with the freeze kept as a backstop. 4) Final add. Everyone agreed on the gate: operating cash flow improving across two reports plus gross margin at 38% or better, rather than a single report.

The high beta (2.10), ~$20 ATR, cash burn and COHR lagging peers like LITE and CIEN are why the total stays capped at 75% instead of going to a full Buy.

What would change the call: a daily close below $250. A sequential drop in gross margin. FCF burn widening again with flat operating cash flow. Another equity or preferred raise. The PhotonLink ramp slipping past late 2026. China transceiver rules restricting COHR's own supply chain. Any of these would mean moving to Hold or Underweight. On the upside, insider buying above $104 or FCF burn clearly narrowing would support filling the full 75%.

Gaps in the evidence: no backlog or order data to confirm the inventory build is for real demand. No capex or FCF guidance. No earnings date. The exact summit date isn't confirmed. The $415–500 analyst targets come from StockTwits and aren't verified. The price history conflicts ('$440 highs' vs. a $220s–$350s range). The $350 target is therefore based on the top of the recent trading range, not on Street estimates.

Price Target: 350.0

Time Horizon: 6-12 months (reassess at each quarterly report)